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Abstract
Structural T1-weighted magnetic resonance imaging (MRI) provides sufﬁcient anatomical
details to measure and track changes in volumes of brain structures. The volumes of brain
structures and changes in them can be used to study the effects of disease, treatment monitor-
ing, aging, learning and brain development. The present thesis investigates the requirements
for performing reproducible quantitative brain volume measurements with automated brain
tissue segmentation tools and gives an error bound on the measurements under various
experimental conditions. A short introduction into the challenges of performing reproducible
brain volume measurements and the main issues that impede the adoption of quantitative vol-
umetric measurements in clinical practice is given, followed by an overview of the acquisition,
reconstruction and automated image segmentation methods used to perform quantitative
brain volume measurements. The ﬁrst part of this study was carried out to investigate the
reproducibility of volumetric measurements preformed on different systems with a standard-
ized ADNI protocol. Systematic biases in volume measurements were observed when there
were changes in systems between the ﬁrst scan and rescan. An important ﬁnding in the
context of patient management was that neither repositioning nor a two-week gap between
the measurements did signiﬁcantly contribute to the uncertainty in volumetric measurements
when compared to the uncertainty in a back-to-back scan-rescan scenario. In the second
part of this study, the impact of new highly-accelerated acquisition protocols on automated
brain tissue volume measurements was investigated. A single system was used to collect the
data and acquisition time was varied at the expense of the SNR. An important outcome of
this study was that for qualitative assessment accelerated protocols provided similar informa-
tion. However, the automated volume measurements with the highly-accelerated protocols
were found biased compared to the measurements with standardized ADNI protocol. In
the ﬁnal part of this study, scaling procedures were investigated as means for compensating
for the observed differences in sequential automated brain volume measurements. A new
image-property-based compensation strategy was proposed and compared to the current
state-of-the-art protocol-based approaches. The main outcomes of this study were that there
are limitations to the current state-of-the-art protocol-based approaches, namely that volume
correction coefﬁcients used in the protocol-based approaches can vary as a function of age,
and there is an indication that the proposed image-property-based approach can be more
robust to the age and contrast-dependent effects compared to protocol-based approaches.
iii
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Résumé
L’imagerie par résonance magnétique (IRM) structurelle pondérée T1 fournit des détails ana-
tomiques sufﬁsants pour mesurer et suivre les changements volumétriques des structures
cérébrales. Les volumes des structures cérébrales et leurs changements peuvent être utilisés
pour étudier les effets d’une maladie, de l’âge, de l’apprentissage et du développement cé-
rébral, ou pour contrôler un traitement. La présente thèse étudie les conditions nécessaires
pour réaliser des mesures quantitatives reproductibles des volumes cérébraux avec des outils
de segmentation automatique du tissu cérébral. Elle donne également une erreur liée aux
mesures faites avec différentes conditions expérimentales. Une courte introduction présente
les déﬁs que pose la réalisation de mesures de volume cérébraux reproductibles ainsi que
les principales difﬁcultés qui entravent l’adoption de mesures volumétriques quantitatives
dans la pratique clinique. Elle est suivie d’une présentation générale des méthodes d’acqui-
sition, de reconstruction et de segmentation automatique de l’image qui sont utilisées pour
réaliser des mesures de volumes cérébraux. La première étude a été conduite pour étudier
la reproductibilité des mesures volumétriques réalisées avec différents systèmes en utilisant
le protocole ADNI standard. Des biais systématiques ont été observés lorsqu’il y avait des
changements de système entre la première acquisition d’une image IRM et la répétition de
cette acquisition. Une importante découverte dans le contexte de la prise en charge des pa-
tients est que ni le repositionnement ni une pause de deux semaines entre deux mesures ne
contribue de manière signiﬁcative à l’incertitude des mesures volumétriques lorsque celles-ci
sont comparées à l’incertitude d’un scénario d’acquisition avec réacquisition immédiate.
Dans la seconde étude, l’impact des nouveaux protocoles d’acquisition hautement accélérés
sur les mesures volumétriques automatiques du tissu cérébral a été examiné. Un système
unique a été utilisé pour collecter les données et le temps d’acquisition a été modiﬁé aux
dépends du rapport du signal au bruit. Le principal résultat de cette étude est que, pour une
évaluation qualitative, les protocoles accélérés fournissent une information similaire aux
protocoles non-accélérés. Cependant, des biais dans les mesures automatiques des volumes
sont présents dans les protocoles hautement accélérés en comparaison au protocole ADNI
standard. Finalement, des procédures de graduation ont été étudiées pour compenser les
différences observées dans les mesures automatiques des volumes cérébraux. Une nouvelle
stratégie de compensation basée sur les propriétés de l’image a été proposée et comparée aux
approches actuelles basées sur les protocoles. Le principal résultat de cette étude est qu’il y a
des limitations aux approches actuelles basées sur les protocoles, à savoir que les coefﬁcients
de correction de volume utilisés dans ces approches peuvent changer en fonction de l’âge. Il
v
y a un indice qu’une approche basée sur les propriétés de l’image peut être plus ﬁable par
rapport à l’âge et aux effets dépendants du contraste en comparaison aux approches basées
sur les protocoles.
Mots clefs : IRM structurel, analyse morphométrique cérébrale, les protocoles MPRAGE accé-
lérés, reproductibilité des résultats d’analyse morphométrique cérébrale
vi
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1 Introduction
1.1 Objectives and overview of this thesis
This thesis investigates the requirements for performing reproducible quantitative volume
measurements of brain structures with automated brain tissue segmentation tools and in-
vestigates the applicability of compensation strategies to mitigate discrepancies between
the measurements. The following is a short history overview with an introduction into the
challenges of reproducible brain volume measurements and the main issues slowing down
the adoption of quantitative volumetric measurements in clinical practice.
Magnetic resonance imaging (MRI) is an imaging modality that is often used in both clinical
and research settings to image anatomy and physiological processes within a human body.
MRI is particularly useful for imaging soft tissues since it provides a better soft-tissue contrast
compared to computed tomography (CT), and is a non-invasive imaging technique that does
not use ionizing radiation in contrast to CT.
The early development of MRI started in 1950 with the detection of the spin echoes by Erwin
Hahn, and generation of a one-dimensional nuclear magnetic resonance (NMR) spectrum by
Herman Carr in 1952. An important milestone was achieved in 1971 by Raymond Damadian
who demonstrated that tumors and normal tissue can be distinguished in-vivo using nuclear
magnetic resonance. In 1973, Paul Lauterbur produced the ﬁrst nuclear magnetic resonance
image. During the following years, MRI has been evolving rapidly to allow imaging of most
parts of the human body. In the present thesis, we focus on brain-imaging.
The ﬁrst commercially available MRI scanners appeared 30 years ago and the adoption of MRI
modality has grown since then. In clinical practice, three dimensional brain-images produced
by MRI are often used to exclude pathology, for disease detection and treatment monitoring.
For instance, the anatomical details provided by structural T1-weighted MRI make it possible
to assess gray matter concentrations within the brain, leading to an active ﬁeld of research
known as brain morphometry. Brain morphometry served as a valuable tool to diagnose
and track changes associated with neurodegeneration, multiple sclerosis, inﬂammatory and
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neurological diseases as well as normal aging, learning and evolution[1, 2, 3, 4, 5, 6, 7, 8, 9, 10,
11, 12, 13, 14, 15]. In order to quantitatively asses these changes, manual, semi-automated,
and automated brain volume segmentation tools are developed by the research community.
However, there is a considerable gap between state-of-the-art research techniques and ev-
eryday clinical practice. Despite promising ﬁndings, quantitative assessment of brain-tissue
volumes is not yet widely used in clinical practice neither it is reﬂected in clinical guidelines
or diagnostic criteria. The reasons of such situation and proposed solutions are summarized
below.
There are several hindrances that slow down the adoption of quantitative volumetric measure-
ments in clinical practice:
1. Manual tissue segmentation approaches are not practical in clinical settings since they
are labor-intensive, require a high degree of expertise, and may introduce operator-
dependent bias. However, these issues can be largely addressed with the use of auto-
mated brain segmentation tools. Automated brain segmentation tools have the potential
to remove the operator-related bias and reduce the labour requirements.
2. Both automated and manual segmentation approaches can be sensitive to variations in
imaging protocols of MRI data and, as a result, may potentially reduce precision of the
volume measurements. In the context of Alzheimer’s disease and dementia, there has
been a substantial effort to standardize MRI acquisition protocols across vendors and
ﬁeld strength[16, 17]. The reproducibility of the standardized ADNI protocol has been
extensively studied [18, 19, 20, 21, 22, 23, 24, 25, 26, 27]. However, the current thesis
extends previous reproducibility studies by decoupling systematic biases on volume
measurements due to hardware (scanner/protocol) and physiology from random offsets
due to repositioning and inter-subject variability.
Rigorous application of the standardized protocols can be challenging. For instance, the
typical acquisition time for a T1-weighted structural brain image is about 10 mins using
the standardized ADNI-1 protocol [16] and 5 mins using ADNI-2 [17].However, with un-
cooperative patients, the use of standardized protocols like ADNI can be difﬁcult due to
patient motion, and reduced acquisition time is desirable. More generally, in a radiology
department, reduction of acquisition time can increase the patient throughput, which
is beneﬁcial both in terms of costs, and overall efﬁciency of utilization of resources avail-
able to the department. Recent advances in MRI hardware and acquisition methodology
can potentially enable further reduction of acquisition time compared to conventional
protocols in both clinical and research settings. This thesis aims to gain further insight
into the exact impact of the use of the highly accelerated protocols on the outcomes of
automated morphometry tools.
3. Normative ranges for volumes need to be available for assessing how brain structure
volumes of a particular subject compare with a healthy population. In order to construct
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normative ranges, a large number of subjects with various demographics needs to be
imaged to capture the inter-subject variation across the population as well as systematic
effects such as normal aging or gender effects. This can be a rather challenging task
from the perspective of protocol standardization across hardware setups and vendors.
For instance, despite the standardization efforts of ADNI, it has been shown that biases
between scanners of different ﬁeld strength are statistically signiﬁcant [20]. Moreover,
in a long-term perspective, accommodating new technological developments would
either require incorporation of compensation strategies or construction of normative
ranges speciﬁc to hardware and protocol setups. This second option would be very inef-
ﬁcient, time consuming, and costly. This work proposes and investigates applicability
of compensation strategies as means to account for differences between protocols and
hardware setups in the construction of normative ranges for brain volumes.
Overall, the present thesis aims to address all of the 3 main issues impeding the adoption
of quantitative volumetric measurements in clinical practice. To achieve these goals, this
work ﬁrst examined the reproducibility of automated volume measurements performed on
data acquired with standardized ADNI protocol[16, 17] on several systems under different
experimental conditions(repositioning, 2-week gap between a rescan). The impact of highly-
acceleratedMPRAGEprotocols on automated volumemeasurements and clinical readingswas
studied. Finally, the applicability of scaling procedures that can be used to put the sequential
volume measurements acquired with different systems and protocols into the same frame of
reference was investigated. The thesis structure is as follows.
• Chapter 1 is an overview of the thesis and a summary of its main contributions.
• Chapter 2 provides the necessary background on image acquisition and reconstruction.
Describes the basis of automated segmentation algorithm used for the purpose of
volumetric assessment.
• Chapter 3 summarizes the effects of using different hardware setups on the outcomes of
automated morphometric assessment when standardized protocols are used.
• Chapter 4 describes the effects of using highly accelerated protocols on the outcomes of
automated morphometric assessment with data acquired on a single system.
• Chapter 5 investigates the applicability of scaling procedures to compensate for discrep-
ancies between hardware setups and protocols.
• Chapter 6 summarizes the main outcomes of the thesis and provides an outlook on the
future work.
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1.2 Main contributions
The main contributions of this thesis are:
• Investigated intra- and inter-scanner reproducibility of volumetric assessment of brain
structures based on T1-weighted whole-brain imaging with standardized protocols
• Compared state-of-the-art whole-brain T1-weighted brain imaging protocols and devel-
oped a new pulse sequence (Segmented MPRAGE)
– P. Falkovskiy, D. Brenner, T. Feiweier, S. Kannengiesser, B. Maréchal, T. Kober, A.
Roche, K. Thostenson, R. Meuli, D. Reyes, T. Stoecker, M. A. Bernstein, J.-P. Thiran,
and G. Krueger, “Comparison of accelerated T1-weighted whole-brain structural-
imaging protocols,” Neuroimage, vol. 124, pp. 157–167, 2016.
– P. Falkovskiy, D. Brenner, T. Feiweier, S. Kannengiesser, B. Maréchal, T. Kober, A.
Roche, K. Thostenson, M. Seeger, T. Stoecker, M. Bernstein, and G. Krueger, “Com-
parison of accelerated T1-weighted whole-brain structural imaging protocols,” in
Proc. Intl. Soc. Mag. Reson. Med. 22, 2014.
– P. Falkovskiy, T. Kober, D. Reyes, K. Steinert, M. Seeger, M. Bernstein, and G. Krueger,
“Segmented Multi-Echo MPRAGE Acquisition for Accelerated T1-weighted Brain
Imaging,” in Proc. Intl. Soc. Mag. Reson. Med. 21, 2013.
• Adapted Segmented MPRAGE pulse sequence to serve as a navigator for motion correc-
tion framework
– M. Waszak*, P. Falkovskiy*, T. Hilbert, G. Bonnier, B. Maréchal, R. Meuli, R. Gruetter,
T. Kober, and G. Krueger, “Prospective head motion correction using FID-guided
on-demand image navigators,” Magn. Reson. Med., 2016.
– M. Babayeva*, P. Falkovskiy*, T. Hilbert, G. Bonnier, B. Maréchal, R. Meuli, J. Thiran,
R. Gruetter, G. Krueger, and T. Kober, “Prospective motion correction with FID-
triggered image navigators,” in Proc. Intl. Soc. Mag. Reson. Med. 23, 2015.
• Investigated the means of correcting for discrepancies between protocols and scanners
• Investigated the applicability of the skull stripping structures for data acquired with
MP2RAGE pulse sequence
– P. Falkovskiy, B. Maréchal , S. Yan , Z. Jin , T. Qian , K. O’Brien , R. Meuli, J. Thiran
, G. Krueger , T. Kober , and A. Roche, Quantitative comparison of MP2RAGE
skull-stripping strategies, Proc. Intl. Soc. Mag. Reson. Med. 24, 2016.
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2 Background
This chapter presents a summary of the concepts that are used in the subsequent chap-
ters. First, it gives a short overview of the physical basis of the magnetic resonance imaging,
describes acquisition and reconstruction of T1-weighted contrasts with MPRAGE pulse se-
quences. Finally, it gives a summary of the automated segmentation algorithm that was used
for the purpose of volumetric assessment throughout the present thesis.
This chapter is based on Haacke, Brown, Thompson, & Venkatesan, 1999; McRobbie, 2003.
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2.1 Magnetic Resonance Imaging
Magnetic resonance imaging is a medical imaging modality that can image both anatomy and
function of the human body through the observation of the interaction of a nuclear spins with
an external magnetic ﬁeld. Spin is an intrinsic property of matter. Due to their prevalence,
spins of protons are often used for human imaging. The spins of protons have two discrete
energy states and when protons are placed in an external magnetic ﬁeld, their spins will
precess around the direction of the external magnetic ﬁeld. The precessional frequency of the
spins of protons is proportional to the magnetic ﬁeld and is given by the Larmor equation:
ω0 = γB0, (2.1)
where γ is a gyromagnetic ratio and B0 is the magnetic ﬁeld. At room temperature, the number
of spins in a lower energy state(same direction as magnetic ﬁeld) will be greater than in the
higher energy state giving rise to the net magnetization(M0) parallel to the magnetic ﬁeld.
It is possible to interact with the spins through the application of a radio frequency (RF) pulse.
When placed in a magnetic ﬁeld, a particle with a non-zero net spin can absorb a photon and
make a transition to a higher energy state. However, since the spin is quantized, the RF pulse
needs to deposit the exact energy that corresponds to the difference between lower and higher
energy states. In the case of a proton placed in an external magnetic ﬁeld, the precessional
frequency of its spin is the same as the frequency of radiation needed to transition between
two states.
Because net magnetization is very small compared to the main magnetic ﬁeld, it is virtually
impossible to measure magnetization in the body at room temperature when it is at equilib-
rium and parallel with the main magnetic ﬁeld B0. However, if the magnetization is tipped in
the transverse plane through the application of a RF pulse, the precession of the net magneti-
zation in the transverse plane would result in a detectable signal. An important effect of the
application of a RF pulse is that it would bring the spins into phase coherence.
A simplistic MR experiment is illustrated in Figure 2.1. Initially, all of the spins are at equilib-
rium precessing around the main magnetic ﬁeld. The main magnetic ﬁeld(B0) is parallel to the
z-axis. If the system of spins is at room temperature, there would be a small excess of spins that
are in the lower energy state. This would result in a non-zero net magnetization that is parallel
to the main magnetic ﬁeld. Following the application of RF pulse, the net magnetization
would be tipped due to non-zero components of the net magnetization in transverse(phase
coherence) and parallel(spins transitioning to higher energy state) to the main magnetic ﬁeld
planes. The spins would start to precess and the system would emit a signal referred to as a
free-induction decay (FID) as the system returns to the equilibrium state. This signal can be
measured by an antenna placed around the subject that is imaged.
The process of the system returning to the equilibrium is known as relaxation. This process
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Figure 2.1: Illustration of the effect of the application of an external radio frequency (RF) pulse
on spins placed in a constant magnetic ﬁeld(B0)
can be described phenomenologically by the Bloch equations.
d
dt
⎛
⎜⎝
Mx(t )
My (t )
Mz(t )
⎞
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⎛
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− 1T2 γBz(t ) −γBy (t )
−γBz(t ) − 1T2 γBx(t )
γBy (t ) −γBx(t ) − 1T1
⎞
⎟⎠
⎛
⎜⎝
Mx(t )
My (t )
Mz(t )
⎞
⎟⎠+
⎛
⎜⎝
0
0
M0
T1
⎞
⎟⎠ (2.2)
where M(t ) is net magnetization and B(t ) is external magnetic ﬁeld.
After the application of the RF pulse, the system will experience only the constant magnetic
ﬁeld B0 that is parallel to the z-axis. By imposing this limiting condition, we can solve the
Bloch equations to describe the relaxation to the equilibrium.
In the plane parallel to the main magnetic ﬁeld, the system would return to the equilibrium
magnetization M0 as follows:
Mz(t )=Mz(0)e
−t
T1 +M0(1−e
−t
T1 ) (2.3)
where Mz(t ) is a component of magnetization parallel to the main magnetic ﬁeld.
In the transverse plane, the system will return to the equilibrium as:
Mx(t )= (Mx(0)cos(ω0t )+My (0)sin(ω0t ))e
−t
T2 (2.4)
My (t )= (My (0)cos(ω0t )−Mx(0)sin(ω0t ))e
−t
T2 (2.5)
where Mx(t ), and My (t ) are the components of magnetization in the transverse plane.
There are two constants that describe this process of decaying to the equilibrium:
• Longitudinal relaxation time(T1) that is due to "spin-lattice" interactions
• Transverse relaxation time(T2) that is due to the "spin-spin" interactions
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White matter (WM), gray matter (GM), and ceribro-spinal ﬂuid (CSF) would exhibit different
T1, and T2 relaxation times. MRI exploits these properties of the tissues to generate the
contrast in images.
2.1.1 Acquisition and Reconstruction
In order to produce 3D image-volumes, the spatial dependence would need to be encoded
into FID signal. This can be accomplished by applying additional spatially varying magnetic
ﬁelds. These spatially varying magnetic ﬁelds are referred as gradients.
Following the application of the RF excitation pulse, it is possible to encode the spatial in-
formation in the ﬁrst 2 dimensions (yˆ ,zˆ) using the phase of the precession of the spins. This
can be accomplished by applying a spatially linearly varying magnetic ﬁeld gradient in both
dimensions (Gy ,Gz) for a short period of time. Initially, right after the application of the gradi-
ent, the spins would precess with different frequencies depending on their spatial position,
and then when the gradient is turned off, the spins would return to the original precessional
frequency. Overall, this would give a spatial-dependent phase offset to the precession of the
spins. For the one remaining dimension (xˆ), after the application of phase encoding gradients,
a linearly spatially varying readout gradient (Gx) is applied in the direction of the remaining
dimension and the signal is sampled while this gradient is applied.
To summarize, this process would result in a signal received by the antenna that would contain
the precessional frequencies of the spins encoding the spatial locations in xˆ dimension and
the phases of the spins encoding the spatial locations in the remaining dimensions yˆ , zˆ. The
signal received from a sample can be summarized as:
S(kx ,ky ,kz)=

dxd ydzρ(x, y,z)e−i2π(xkx+yky+zkz ) (2.6)
where ρ is a density of spins emitting the signal and kx = γ2π
∫t d tGx(t), ky = γ2π
∫t d tGy (t),
kz = γ2π
∫t d tGz(t ) deﬁne the k-space trajectory through the application of gradients(Gx ,Gy ,Gz).
It is possible to reconstruct the original image ρ(x, y,z) by applying an inverse Fourier trans-
form. However, a big challenge is to manipulate the gradients in a way that would efﬁciently
sample the k-space.
2.1.2 MPRAGE Acquisition
Magnetization Prepared Rapid Acquisition by Gradient Echo(MPRAGE) [28] pulse sequence
is often used in 3D T1-weighted(T1w) brain-imaging due to a an excellent GM-WM contrast.
A typical use case in brain-imaging for this pulse sequence would be to provide anatomical
information. This anatomical information can be later used to track the changes in tissues as-
sociated with disease, ageing, treatment, or to provide the supporting anatomical information
to other imaging sequences or modalities.Typical images acquired using an MPRAGE pulse
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Figure 2.2: Sample MPRAGE images from a single subject showing saggital, axial, and coronal
slices.
sequence with ADNI-2 protocol parameters[17] are illustrated in Figure 2.2.
The sequence can be split into 3 parts: preparation, acquisition and recovery (Figure 2.3).
Typical preparation module consists of a 180° inversion pulse followed by a delay. First, the
inversion pulse would invert the longitudinal magnetization of all excited tissues. During
the delay period, the longitudinal magnetization of GM, WM, CSF would recover at different
rates due to differences in the tissue-speciﬁc T1 values. The differences in the recovery of
longitudinal magnetization between the tissues would give rise to a contrast between the
tissues (Figure 2.3).
The acquisition part consists of a gradient echo readout that would use low-ﬂip-angle ex-
citation pulses. Typically per preparation part, the acquisition module would apply phase
encoding and frequency encoding gradients to sample data along the readout direction(xˆ)
and partition direction(zˆ) while keeping the line direction (yˆ) ﬁxed. Finally, following the
acquisition module, the delay portion of the sequence allows the magnetization to recover.
The subsequent repetitions of these steps would ﬁll the k-space through sampling the data
along the line direction (yˆ) dimension.
2.1.3 Conventional parallel imaging(GRAPPA)
In the current clinical and research practice GRAPPA- [29] or SENSE-type accelerations [30]
are often used reduce the acquisition time. The conventional parallel imaging techniques
reduce the acquisition time through undersampling of the k-space data in one phase-encoding
direction (1D).
Let us consider 1D GRAPPA reconstruction that is used in the ADNI-2 protocol. The data is
undersampled in ky direction. First, we deﬁne S(ky ) as acquired signal, and S(ky +mδky ) as
9
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Figure 2.3: Top: sequence diagram of the MPRAGE pulse sequence. Phase encoding gradient
(GPE ), readout gradient (GRO),radio frequency pulse(RF). Bottom: evolution of longitudinal
magnetization for WM, GM, and CSF structures as a function of time.
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reconstructed signal. We can write 1D GRAPPA reconstruction as:
S(ky +mδky )= Gˆ(y,m)S(ky ),m = 1..R−1 (2.7)
where Gˆ(y,m) is a weight matrix that can be calculated from the reference lines.
When reference lines are acquired, we have the knowledge of both S(ky ) and S(ky+mδky ), but
we do not know the weight matrix. The weight matrix Gˆ(y,m) can be calculated by computing
a pseudo-inverse as follows:
Gˆ(y,m)= S(ky +mδky )(S(ky )HS(ky ))−1(S(ky )H (2.8)
2.1.4 Automated Brain Morphometry
Figure 2.4: Sample segmentation results from a single subject showing saggital, axial, and
coronal slices. Blue: white matter; Green: grey matter; Red: CSF.
The automated brain tissue segmentation algorithm used in the present thesis is described
in [12]. A short overview of the algorithm is presented in this section. The segmentation
algorithm uses a template. The template consists of a T1-weighted MPRAGE scan acquired
with ADNI-2 [17] protocol parameters and a mask that deﬁnes voxels that belong to various
anatomical structures. The mask image was drawn and reviewed by several neurologists. The
following anatomical structures are present in the mask image: the total intracranial volume
(TIV) deﬁned by the hemispheric and cerebellar gray matter (GM), white matter (WM) and
the intracranial cerebrospinal ﬂuid (CSF), lateral, third and fourth ventricles, cerebellum,
thalamus, putamen, pallidum, caudate nucleus, and hippocampus. The ﬂow of the algorithm
can be summarized as follows.
First, an image template that outlines the tissue structures of interest is registered into the
input image space. The registration of the template consists of estimating the 9 parame-
ter(translation, rotation, and anisotropic scaling) afﬁne transform [31] followed by the estima-
tion of free-form diffeomorphic displacement ﬁeld [32]. Following the template registration,
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an additional bias ﬁeld correction similar to [33] is applied to the input image volume.
Based on the estimated parameters of the transformation of the template image, masks
deﬁning the voxels that belong to each structure of interest are resampled into the image
space. The voxels that belong to the TIV in the input image are deﬁned based on the resampled
masks of the template.
The following steps of the tissue segmentation algorithm are restricted to the TIV. The signal
intensities are modeled as a ﬁve-class Gaussian mixture model that additionally incorporates
a stationary Markov–Potts prior model[34, 35]. The classes used in this model roughly corre-
spond to ventricular CSF, sulcal CSF, cortical GM, deep GM and WM. The model is ﬁt using
the variational expectation-maximization (VEM) algorithm and will output ﬁve posterior
probability maps. The masks and volume estimates corresponding to CSF/GM/WM structures
are then computed from the posterior probability maps. For the remaining structures, the
tissue probability maps are combined with the masks of the resampled template to produce
tissue volume estimates and corresponding masks.
A sample output of the label masks is illustrated in Figure 2.4.
12
3 Reproducibility of volumetric data
acquired with a standardized T1-
weighted brain-imaging protocol
With advances in medical imaging technology, clinical radiology is increasingly requested to
provide sensitive markers to measure disease progression, to differentiate pathology from
healthy aging, and to monitor therapy response. This chapter quantitatively characterizes
MPRAGE scans acquired with standardized ADNI protocol parameters across different sys-
tems, ﬁeld strength, shimming, and brain physiology based on basic image quality met-
rics(SNR,CNR) and examines the impact of scanner’s model, ﬁeld strength, protocol param-
eters, shimming, and brain physiology on the reliability and reproducibility of automated
volumetric brain measurements in clinical settings.
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3.1 Introduction
Automated brain morphometry of magnetic resonance imaging (MRI) data is becoming an
important tool in studies aiming to quantify disease progression, drug efﬁciency or normal ag-
ing. For instance, hippocampal atrophy is recognized as a biomarker for Alzheimer Dementia
(AD) and mild cognitive impairment (MCI)[36, 37]. In the context of multiple sclerosis(MS), in
addition to lesion count and volume, the atrophy rate of white matter(WM), grey matter(GM),
thalamus, and caudate structures can be used as predictor for clinical status [7, 11, 13].
For the purpose of morphometric assessment, the magnetisation-prepared rapid acquisition
gradient-echo (MPRAGE) pulse sequence [28] is often used to produce T1-weighted images
because it exhibits excellent grey-white matter contrast. In practice, it is difﬁcult to conduct
a large cross-sectional or longitudinal study on the same system and as a result there has
been a substantial effort to optimize reliability and reproducibility of the morphomteric
measurements across different systems and ﬁeld strength through the use of standardized
protocols and regular phantom calibration scans[8, 16, 17].
However, even when standardised protocols are used, automated volume measurements may
be affected by physiological factors (e.g., dehydration), and system-speciﬁc factors such as
shim settings, ﬁeld strength, scanner model, and software version[20, 22]. Depending on
the exact experimental setup, these factors may affect both cross-sectional and longitudinal
exams. In cross-sectional studies, they may affect the ability to detect differences between
groups if subjects are scanned on different types of systems. In longitudinal studies, important
anatomical changes over time may remain undetected due to the large variance in image
content of incompatible sequential measurements.
Some of these pitfalls can be addressed by careful adoptions of the patient scheduling, often
at the cost of increased complexity, and reduced efﬁcacy and productivity of the radiology
department.
This work quantitatively characterizes MPRAGE scans acquired using different scanners, pro-
tocols, shim settings, and physiological conditions to investigate reliability and reproducibility
of brain volumetry under clinical conditions. The reproducibility of the standardized 5-minute
ADNI-2 protocol has been extensively studied [18, 19, 20, 21, 22, 23, 24, 25, 26, 27]. However,
the current study aims to extend previous reproducibility studies by decoupling systematic
offsets to volume measurements due to hardware (scanner/protocol) effects from random
offsets due to repositioning, and physiology with linear mixed-effect model analysis. This
decoupling of ﬁxed effects from random effects makes it possible to examine the importance
of each effect individually and to get a deeper insight into the merit of applying compensation
strategies.
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3.2 Materials and Methods
3.2.1 Acquisition
Experiments were performed on four clinical MRI scanners (Siemens Healthcare, Erlangen,
Germany):
1. 3 T MAGNETOM Skyra (20-channel head/neck coil)
2. 3 T MAGNETOM Prisma (64-channel head/neck coil)
3. 1.5 T MAGNETOM Avanto (12-channel head coil)
4. 1.5 T MAGNETOM Espree (12-channel head coil)
22 healthy young subjects(20-39 years old) were imaged on each scanner after obtaining a
written and informed consent. The physiological parameters hydration status and arterial
blood pressure of each subject were controlled prior to each acquisition. The following
MPRAGE protocols were used:
(a) 3 T - scanners: 5:12-minute protocol as used in ADNI-2 (TR/TI/BW/α = 2300 ms/900
ms/240 Hz/px/9 deg.) [17] but with isotropic 1mm resolution
(b) 1.5 T - scanners: 4:42-minute protocol as used in ADNI ( TR/TI/BW/α = 2400 ms/1000
ms/180 Hz/px/8 deg., 1.25x1.25x1.20mm3) [16] but two-fold accelerated using GRAPPA
(R=2)
For Avanto and Prisma scanners, themeasurement program consisted of fourMPRAGE volume
acquisitions:
(R0) Reference MPRAGE scan
(R1) Repeat scan acquired in the same session and back-to-back with R0 (“best case” scan-
rescan variability)
(R2) Scan with repositioning of the subject during the same session as R0 (adds the effect of
repositioning and shim changes to R1)
(R3) Scan conducted within 2 weeks after R0 (adds physiological variances to R2)
At Skyra and Espree scanners, the measurement program consisted of only (R0) and (R3)
acquisitions.
For all acquisitions, FOV placement was guided by a scanner-integrated AutoAlign feature. In-
tensity normalization was performed using a scanner software-integrated pre-scan procedure,
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and an adaptive coil combination mode [38] was used to reconstruct the image volumes for all
acquisitions leading to 264 MPRAGE image volumes. In addition to the reconstructed imaging
data, all raw data from 3T systems were saved for retrospective modiﬁed reconstructions.
3.2.2 Data Analysis
Quantitative volumetric measurements and label maps deﬁning voxels that belong to each
structure were computed using the prototype morphometry package MorphoBox [39, 12] for
grey-matter (GM), white-matter (WM), normalized whole brain volume (NBV), cerebrospinal
ﬂuid (CSF), hippocampus, thalamus, putamen, caudate, and pallidum. Segmentation software
was run in a fully automated manner and no manual editing was done at any stage of the
processing. Segmentation results were visually inspected for gross errors.
Contrast-to-Noise Ratio (CNR)
Prior to CNR assessment, a separate B1 bias ﬁeld correction [35] was applied to all acquired
data in addition to intensity normalization performed using a scanner-integrated pre-scan
procedure.
CNR was assessed using label maps provided by MorphoBox as:
CNRcs f −gm = (μgm−μcs f )
2
(σ2cs f +σ2gm)
(3.1)
CNRgm−wm = (μwm−μgm)
2
(σ2gm+σ2wm) (3.2)
where μcs f , μgm , μwm were median intensities and σ
2
cs f , σ
2
gm , σ
2
wm were image intensity
variances within CSF, GM and WM volumes. The intensity variances were estimated through
computing median absolute deviation as opposed to computing the variances directly since
this would render them less sensitive to outliers. The differences in CNR of different scan-
ner/protocol variants were tested with the Wilcoxon rank-sum test [40].
Signal-to-Noise Ratio (SNR)
Using a retrospective reconstruction based on the raw data, voxel-wise SNR (μsi gnal/σnoi se)
quantiﬁcation was performed using a prototype implementation of the pseudo-multiple
replica approach [41] with 8 pseudo-replicas. The variance of additional synthetic noise used
to compute σnoi se was estimated based on a short prescan consisting of 128 readouts having
512 sampling points each, including oversampling, without an excitation pulse. To improve
the estimation of σnoi se , a 2D 5x5 region of neighboring pixels was used to estimate σnoi se
using a moving-averages fashion according to [42]. Average SNR in the brain stem, WM, and
GM was computed for 5 subjects from the anatomical label maps produced by MorphoBox.
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Brain stem, WM and GM were chosen as those tissue types that represent regions-of-interest
(ROI) of known differences in the coil performance in the centre of the coil and the proximity
of the coil elements [43].
Linear Mixed-Effect Model Analysis
Linear mixed-effect models are prime tools to analyze cross-sectional data with repeated
measurements per subject [44, 45]. They are able to deal with missing data in contrast to
the repeated measurement ANOVA [44, 45]. In the present study, we did not have R1 and R2
sessions acquired on the Espree and Skyra scanners. Therefore, due to the presence of the
missing data, a linear mixed-effect model was used for the subsequent analysis.
Prior to further analysis, volumes of all structures were normalized by the total intracranial
volume (TIV). A linear mixed-effect model [44] of the form:
yi = Xiβ+Ziγi +
i (3.3)
was ﬁt on the volumetric data from all subjects with the R software (version 3.1.1) using lme4
package [44]. In this model, yi was a vector of serial volume measurements for subject i, Xi
was a matrix that models the scanner/protocol type, gender and age of the subject (ﬁxed
effects). Random effects consisted of both subject-dependent and session-dependent offsets
modelled by the matrix Zi ; β and γi were vectors of unknown regression coefﬁcients and
the residual error 
i represented the scan-rescan variability. Regression coefﬁcients βwere
assumed to be the same across all of the subjects while γi and 
i were treated as a random
variables. Note that effects of scanner/protocol, subjects’ gender and age, subject-dependent
and session-dependent offsets were modelled as additive terms and are in percentage of TIV
units.
Both variability due to scan-rescan and additional variability (repositioning, physiology etc.)
as detected with (R2) and (R3) were assumed to be same across scanner models based on the
ﬁndings previously demonstrated in [20].
The Satterthwate’s approximation was used to estimate the number of degrees of freedom
with lmerTest package [46], and generalized t-tests with Bonferroni correction[47] were used
for post-hoc multiple comparisons of the normalized volume estimates between all combi-
nations of scanner-dependent regression coefﬁcients. The differences between the scanner-
dependent regression coefﬁcients were compared to the intra-subject standard deviation in
order to assess the importance of the differences.
The linear mixed-effect model not only estimated the mean normalized volume for each
condition deﬁned through the ﬁxed effects but also gave structure to the random effects and
estimated of the variability due to scan-rescan, additional variability due to repositioning (R2),
and additional variance due to a 2-week gap between a rescan (R3). An important consequence
of formulating our problem in this form(Equation 3.3) was that we were able to distinguish
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subject-speciﬁc variance var (yi |γi ,0) and means E(yi |γi ,0) from marginal variance var (y)
and means E(y).
The estimates of variance due to scan-rescan, additional variability due repositioning(R2),
and additional variability due to a 2-week gap between a rescan (R3) were compared to the
inter-subject variance to assess the importance of the random effects. It is important to note
that the conditional subject-speciﬁc variance of uncertainties in measurements is given by
the sum of the back-to-back scan-rescan variance and depending on the acquisition scenario
either the variance due to repositioning or the variance due to the 2-week gap between a
rescan.
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3.3 Results
Figure 3.1 shows sample images from one subject scanned during R0 session from all scanner-
s/protocols (4 in total) acquired in this study. For all of the shown images, the windowing was
set to the same level. Upon visual inspection, it is difﬁcult to see large differences between
these four acquisitions. However, acquisitions from Prisma scanner have visibly higher SNR
and CNR in the cortical region compared to the rest.
Figure 3.1: Images within one session with the same subject during R0 session.
Quantitative SNR assessment conﬁrmed the visual inspection. SNR appeared to be well-
matched on Avanto, Espree and Skyra scanners, but higher on the Prisma scanner for both GM
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and WM (p<0.05, Figure 3.2). Mean SNR in WM: 38.64, 37.48, 49.84, 39.31; GM: 29.01, 28.95,
38.86, 28.19; Brain Stem: 23.30, 23.24, 21.71, 21.31 were observed on Avanto, Espree, Prisma,
and Skyra scanners.
Figure 3.2: SNR for different scanner combinations using the segmentation masks from
MorphoBox. Error bars show standard deviations across the subjects.
The results of the CNR assessment of all protocols/scanners used in this study are shown in
Figure 3.3. Median GM-WM CNR 5.52, 5.23, 6.89, 6.63 and GM-CSF CNR 3.34, 3.25, 3.02,
3.01 were observed on Avanto, Espree, Prisma, and Skyra scanners. There were systematic
differences in CNR (GM-WM and GM-CSF) between scanners of different ﬁeld strength (Figure
3.3).
Figure 3.3: CNR for different scanner combinations (R0 session) using the segmentation masks
from MorphoBox. Error bars show standard deviations across the subjects. The outliers are
indicated as points.
The regression coefﬁcients of ﬁxed effects and estimates of the standard deviations of random
effects ﬁt by the linear mixed-effect model are shown in Figure 3.4 and Table A.1. Note that
there is a signiﬁcant effect of gender on the normalized volumes of grey matter, white mater
and caudate. Males tend to have a signiﬁcantly smaller percentage of grey-matter and caudate
volumes whereas females tend to have a signiﬁcantly smaller percentage of white-matter
volume. The effect of age was found to be signiﬁcant only for global grey matter volumes.
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Figure 3.4: Regression coefﬁcients as ﬁt by the linear mixed-effect model. Fixed effects are
shown in red. Random effects are shown in blue. * p<0.05; ** p<10-2; *** p<10-3
Figure 3.5: Volume differences for all possible scanner combinations. Each coloured bar
represents a difference between scanner regression coefﬁcients. The solid grey rectangle
represents inter-subject variability (+/- 1 standard deviation). The dashed rectangle represents
intra-subject back-to-back scan-rescan variability (+/- 1 standard deviations). * p<0.05; **
p<10-2; *** p<10-3
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The post-hoc multiple comparison of the regression coefﬁcients of each scanner is illustrated
in Figure 3.5 and Table A.2. The differences in ﬁxed effect regression coefﬁcients represent a
difference in mean estimates between two scanners and are in a percentage of the TIV units.
Figure 3.5 also shows the inter-subject and scan-rescan standard deviations as estimated by
the linear mixed-effect model and adjusted for the effects of scanner, age, sex, repositioning
and 2-week gap between a rescan. The 1.5T - 3T differences constituted a considerable portion
of inter-subject variability, i.e. 39% (caudate), 45% (hippocampus), 113%(pallidum), 45%(puta-
men), and 76%(thalamus) of the inter-subject standard deviation (solid grey area in Figure
3.5). Note that when compared to back-to-back scan-rescan variability, these differences were
largest in the case of volume estimates of thalamus, and were of the order of scan-rescan
variability for the rest of the small structures. However, they were mostly insigniﬁcant within
the ﬁeld-strength and constituted a small proportion of the inter-subject standard deviation.
Results from GM, WM, NBV, and CSF tissues were heterogeneous in this respect.
Figure 3.6 illustrates the contribution of individual components to random effects (back-
to-back scan-rescan, repositioning, and physiology) as ﬁt by the model. The scan-rescan
differences in back-to-back scanning scenario signiﬁcantly contributed to the total variance
and represented a signiﬁcant proportion of between-subject variance for all of the investi-
gated structures. Note that the scan-rescan variance of volume estimates constituted a large
proportion of the inter-subject variance for pallidum, white matter and grey matter while
scan-rescan variances of thalamus and caudate volumes were small compared to inter-subject
variance.
In the case of repositioning between the measurements or a 2-week-gap between a rescan, the
total variance of an uncertainty in the measurements for a given subject is the sum of the back-
to-back scan-rescan variance(R0) and the additional variance either due to repositioning(R2)
or 2-week-gap between a rescan (R3). Both repositioning (R2) and 2-week-gap between a
rescan (R3) did not signiﬁcantly contribute to the total variability compared to back-to-back
scans and between-subject variability. Note that compared to the other investigated structures,
volumes of grey matter had a relatively large back-to-back scan-rescan variability as well as
strong contribution from both repositioning and a 2-week gap between scanning sessions.
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Figure 3.6: Random components of variability expressed as percentage of between-subject
variance, scan-rescan (R1)- red, additional variance due to repositioning (R2) - green, addi-
tional variance due to 2-week-gap between rescan (R3) - blue.
3.4 Discussion
This work quantitatively characterised MPRAGE scans acquired with protocol parameters
similar to ADNI and tested the impact of scanner’s model, ﬁeld strength, protocol parameters,
shimming, and brain physiology on the reliability and reproducibility of volumetric brain
assessment in clinical settings.
Consistent with theoretical considerations taken in ADNI protocol design, SNR appeared to be
well-matched on Avanto, Espree and Skyra scanners. However, it appeared to be higher on the
Prisma scanner for both GM and WM (p<0.05, Figure 3.2), which can be presumably explained
by the use of the 64-channel head coil (Prisma) vs. 12- and 20-channel coils otherwise. Note
that GM-WM CNR appeared to be higher on 3 T systems compared to 1.5 T. This increase
of GM-WM CNR on 3 T systems can be attributed to the small differences in the respective
protocol parameters including the inversion times.
In this study, we decoupled systematic offsets to volume measurements due to hardware,
and protocol effects from random offsets due to repositioning, and physiology using a linear
mixed-effect model analysis.
There was a signiﬁcant effect of gender on the normalized volumes of grey matter, white mater
and caudate that was consistent with previously reported studies [48, 49]. However, the effect
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of age was only signiﬁcant for grey matter. The absence of signiﬁcant age effect for other
structures can be attributed to the narrow age range of the subjects used in this study.
Systematic biaseswere observed in variability of volumemeasurements of the caudate nucleus,
hippocampus, pallidum, putamen, and thalamus structures between 1.5T and 3T systems.
However, they were mostly insigniﬁcant within ﬁeld-strength. These systematic differences
between 1.5T and 3T systems can be explained by the changes in contrast and differences
in protocol parameters that, for example, differences in voxel size can give rise to different
partial volume fractions. Total volumes of GM, WM and CSF were also found different across
scanners of the same ﬁeld strength. One of the factors responsible for this heterogeneity can
be the system-speciﬁc residual bias-ﬁeld left after application of B1 bias ﬁeld correction [35].
Within small structures we do not expect to observe large variations of residual bias ﬁeld and
expect to have pure CNR/protocol effects.
In the context of patient management, an important ﬁnding is that overall the effects from
repositioning (R2), and 2-week rescan (R3) scenarios did not signiﬁcantly contribute to the
total variability when compared to the back-to-back scan-rescan (R1) scenario. Note that
scan-rescan standard deviation of volumes of thalamus structure was small compared to the
1.5T - 3T protocol differences and between-subject standard deviation. For the rest of small
structures examined in this study, the scanner/protocol related effects were of the same order
as scan-rescan variability. Comparatively smaller scan-rescan variability of the thalamus can
be presumably explained by its more stable shape across subjects compared to other central
nuclei that may facilitate robust automated segmentation.
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3.5 Conclusion
In summary, without the use of sophisticated correction strategies, compatibility of serial
and cross-platform scans can be best reached by minimizing differences in ﬁeld, protocol,
hardware, software, and physiology. Intra-subject scan-rescan variabilities were on average a
factor of two smaller than the inter-subject variability and might be impacted by algorithmic
instabilities, e.g. during registration (i.e. for small brain structures) and noise ﬁgures (e.g. for
GM and WM )[50].
Two encouraging ﬁndings of this study were that (a) repositioning, re-shim and physiology
conditions appeared as minor contributors to total variability in volumetric assessment and
(b) protocols at equal ﬁeld strength introduced an insigniﬁcant bias for the NBV, caudate
nucleus, hippocampus, pallidum, putamen, and thalamus structures.
Signiﬁcant biases found in this study appeared when ﬁeld strengths, voxel size, contrasts
differed and noise levels were modulated. The employed 1.5T and 3T protocols slightly differ
in contrast and resolution – factors which cannot be disentangled using the data collected
in the current study. However, since these effects are deterministic, correction strategies can
be applied to enable comprehensive pooling of imaging data in cross-sectional studies or
improved atrophy assessment in longitudinal studies.
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4 Optimization of acquisition strategies
and comparison of state-of-the-art
T1-weighted whole-brain protocols
Recent advances in MRI hardware and acquisition methodology promise improved leverage
of the MR signal and more benign artefact properties in particular when employing increased
acceleration factors in clinical routine and research. In this chapter, four variants of a four-
fold-accelerated MPRAGE protocol (2D-GRAPPA, CAIPIRINHA, CAIPIRINHA elliptical, and
segmented MPRAGE) are quantitatively investigated based on clinical readings, basic image
quality metrics (SNR, CNR), and results of automated brain tissue volume segmentations.
The experiments were performed on a single system. The results are benchmarked against a
widely-used two-fold-accelerated 3T ADNI MPRAGE protocol that was investigated in Chapter
3.
This chapter is adapted from already published work (Falkovskiy et al., 2016).
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4.1 Introduction
The 3D magnetisation-prepared rapid acquisition gradient-echo (MPRAGE) pulse sequence
[28] with Alzheimer’s Disease Neuroimaging Initiative protocol (ADNI-2) [17] parameters is a
well-established standard for multi-site and longitudinal MRI studies that involve T1-weighted
imaging of the human brain. Both in routine clinical and research settings, reduced MRI scan
times are desirable for increased patient throughput, improved patient comfort, and better
management of patient motion. The 3T imaging protocol of the ADNI employs conventional
two-fold parallel imaging [29] to reduce the acquisition time of a whole-brain MPRAGE scan
from 9 min in the original ADNI-1 protocol [16] to 5 min in ADNI-2. Recently, several strategies
have been proposed to further reduce the acquisition time in 3D structural-brain-imaging
protocols beyond conventional parallel imaging, e.g. 2D-GRAPPA [51], CAIPIRINHA [52, 53],
and segmented MPRAGE [54].
Because of the excellent tissue contrast, the 3D T1-weighted MPRAGE images are appreciated
for radiological reading. Moreover, quantitative assessment of brain tissues and the volume of
individual brain structures has become an important tool in more research-oriented applica-
tions of the MPRAGE [5, 55, 56, 57, 12]. For instance, studies aiming at quantiﬁcation of disease
progression, drug efﬁciency or normal aging apply serial imaging to assess structural changes
over time. Since the expected effect sizes in normal aging and disease (e.g. increased atrophy
rates) are often subtle over time, it is vital to understand the reliability and reproducibility of
the imaging-based quantitative measurements and to understand any inconsistencies that
may appear when changing the pulse sequence between longitudinal repeat scans.
The reproducibility of the reference protocol (5-minute ADNI-2) has been studied extensively
[18, 19, 20, 21, 22, 23, 24, 25, 26, 27] However, to our knowledge, the inﬂuence of further accel-
erations obtained by applying 2D-GRAPPA, CAIPIRINHA or segmented MPRAGE protocols on
volumetric brain measurements and clinical readings has not been reported so far.
In this work, we aim to assess the reliability of the data obtained on the same platform across
these accelerated protocols both qualitatively and quantitatively. The qualitative analysis
is carried out by an experienced observer. The quantitative analysis is performed through
assessing the reproducibility of volume measurements with automated brain segmentation
algorithm [39, 12] contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR) measurements
[41].
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(a) 2D-GRAPPA (b) CAIPIRINHA
(c) Segmented MPRAGE
Figure 4.1: K-space sampling patterns for the accelerated MPRAGE variants. Solid squares
represent acquired lines. Squares with stripes represent lines acquired with a second echo. (a)
2D-GRAPPA acceleration with 2x2 undersampling; (b) CAIPIRINHA with 2x2 undersampling
and shift 1; (c) Assignment of echoes in segmented MPRAGE
4.2 Theory
Conventional GRAPPA- [29] or SENSE-type accelerations [30] are often used in clinical set-
tings. Both methods obtain acceleration by undersampling of the k-space data in one phase-
encoding direction (1D). In most cases, only moderate accelerations are employed due to
increased aliasing and noise ampliﬁcation (g-factor penalty) with higher acceleration fac-
tors. In order to overcome those limitations partly, and assuming that there is sufﬁcient
SNR, it is possible to further generalize the conventional GRAPPA approach to 2D for higher
accelerations [51].
A modiﬁed undersampling pattern used in 2D-GRAPPA is illustrated in Figure 4.1a. 2D-
GRAPPA allows for a more effective exploitation of the coil sensitivities of contemporary
high-channel-count receive arrays which vary in both phase-encoding directions, resulting in
a reduced g-factor compared to 1D-GRAPPA with the same total acceleration. This advantage
can be further improved by using the CAIPIRINHA [52, 53] approach, which shifts the aliasing
pattern by introduction of an additional CAIPIRINHA shift parameter (Figure 4.1b).
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In addition to parallel imaging techniques, a common approach to reduce scan time is to use
elliptical scanning [58]. Elliptical scanning does not sample the corners of k-space and hence
reduces the acquisition time.
A segmented MPRAGE approach accelerates the acquisition using a different method which
does not rely on coil sensitivity variations in contrast to parallel imaging techniques [54]. The
standard acquisition scheme is modiﬁed to allow acquisition of multiple echoes with bipolar
gradient readouts. Between the readouts, phase-encoding blips are inserted so that multiple
portions of k-space are sampled per excitation. The echoes are grouped so that the ﬁrst echoes
are acquired in the centre of k-space to ensure the intended contrast (Figure 4.1c). A phase
correction algorithm similar to the one used for EPI acquisitions is applied to remove phase
inconsistencies between k-space lines acquired in the different echoes with differing polarity.
This correction is computed based on the lines acquired in the centre of k-space. Notably, this
segmented approach can be introduced in addition to parallel-imaging-based acceleration.
4.3 Materials and Methods
4.3.1 MR Acquisition
All experiments were performed on a standard clinical 3T MRI (MAGNETOM Skyra, Siemens
Healthcare, Erlangen, Germany) equipped with a 32-channel head coil array. The measure-
ment protocol consisted of ﬁve 3D MPRAGE volume acquisitions with protocol parameters
similar to the ADNI-2 MPRAGE protocol settings (TR/TI= 2300/900 ms, α = 9 deg., BW=240
Hz/pixel, readout in superior-inferior direction) [17] but with 1 mm isotropic resolution at a
FoV of 256x240x176 mm3: (a) T1w ADNI-2 protocol with 2-fold GRAPPA acceleration (TA=5:12
min) [17] which is used as reference and that we will refer to as reference ADNI-2; (b) 2D-
GRAPPA with 4-fold (2x2) undersampling (TA=2:59 min) [51]; (c) CAIPIRINHA with 4-fold
undersampling (2x2 shift 1 in z direction) (TA=2:59 min) [52]; (d) CAIPIRINHA same as c but
with additional elliptical scanning option, further reducing scan time (TA=2:40 min) [52];
(e) segmented MPRAGE with 4-fold acceleration based on combining conventional parallel
imaging (2-fold) and a two-echo segmented acquisition (BW=480 Hz/pixel, TA=3:15 min)
[54]. All 1-D undersampled scans utilized 32 reference lines for reconstruction of the GRAPPA
weights, while the 2-D undersampled scans utilized a 32x32 lines reference region.
For the segmented MPRAGE acquisition, the bandwidth was increased to maintain the echo
spacing equal to the one of the reference ADNI-2 protocol. With the exception of the reference
T1w ADNI-2 measurement, all scans were acquired using in-house prototype sequences. The
order of the scans was randomized between sessions.
22 subjects (12 male and 10 female, age 20-44 years, mean 30 ± 6.0 years) were imaged. The
subjects were screened prior to enrolment in this study based on a health-assessment ques-
tionnaire. Only the subjects in good health and without a history of neurological diseases
were considered. The exclusion criteria included: any known active medical conditions;
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hypertension; excessive smoking; excessive alcohol consumption; drug addiction; diabetes
mellitus; history of signiﬁcant vascular events (i.e., myocardial infarction, stroke or peripheral
vascular disease); history of malignant neoplasia of any form; history of cardiac, lung, liver, or
kidney failure; active or inadequately treated thyroid disease; active neurological or psychi-
atric conditions; history of head trauma with loss of consciousness. After obtaining written
consent, each subject was scanned with the ﬁve MPRAGE variants within one session under
an IRB-approved protocol. FOV placement was guided by the scanner-integrated AutoAlign
feature. Intensity normalization was performed using a scanner software-integrated pre-scan
procedure and an adaptive coil combination mode [38] was used to reconstruct the image
volumes for all of the protocols used in this study.
4.3.2 Image Processing Pipeline and Analysis
Qualitative
The data were graded by an experienced image analyst from the ADNI MR Core. The analyst
was blinded with respect to protocols. First, each volume was rated with respect to the
presence of motion artefacts (none, mild, severe) and overall image quality on the scale of 1-3
based on the presence of blurring/ringing/ghosting or other artefacts (1: good, 2: fair, 3: very
low quality). No separation on the nature of artefacts that contributed to overall image quality
score was made.
Second, following this ranking, if two or more image volumes were assigned the same image
quality grade, image volumes were presented side by side and the observer made a subjective
decision which image had higher image quality relative to each-other. In this fashion, relative
rankings within a session were constructed with a relative scale (1: best, 5: worst). The grade
of 1 is assigned to the volume with the best image quality in the session and 5 to the volume
with the worst image quality relative to the other scans in the session. Note that it should
be considered as a limitation of these qualitative rankings the fact that the observer did not
have to justify his choice, and only a single observer was used. These scores were averaged
across the sessions, and statistical difference between the protocol variants was tested with
the Wilcoxon rank-sum test [40] since we did not expect scores to be normally distributed.
Quantitative
The data was passed through the in-house-developed automatic segmentation framework
MorphoBox [39, 12] to compute the volumes of a number of brain tissues and structures: total
intracranial volume (TIV), grey matter (GM), cortical grey matter (cGM), white matter (WM),
hippocampus, thalamus, caudate, putamen, pallidum and brain stem. Label masks that deﬁne
voxels belonging to a particular tissue type or structure were also computed. In order to assess
the consistency of the volumetric observations, intra-class correlation coefﬁcients (ICC) [59]
between all possible combinations of protocol variants were computed. The model used in
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this study for ICC computation treated subjects as randomly sampled from a larger population
and the acquisition protocols employed in this study as ﬁxed parameters.
In order to evaluate a potential systematic bias in the volumetric results, normalized volumet-
ric differences (D) between the reference protocol (Vr ) and each variant (Vv ) were computed
for each structure as:
D(Vr ,Vv )= (Vv −Vr )
(Vr +Vv )
, (4.1)
where D(Vr ,Vv ) is in the range [-1,1]. Normalized volumetric differences were averaged across
the subjects. All possible choices of the reference protocol (Vr ) were examined. The statistical
signiﬁcance of the difference from a zero median in normalized volumetric differences was
tested using Wilcoxon signed-rank test [40] because the differences were not expected to be
normally distributed.
Based on the ICCs and normalized volume differences, the most consistent accelerated pro-
tocol was selected when compared to the reference ADNI-2 protocol. For this protocol, the
normalized volume differences were recomputed using the methodology described in [21]
and then compared to the scan-rescan reproducibility study of reference ADNI-2 protocol
[21].
The gold-standard method for SNR computation is the multiple-replica approach that consists
of imaging the same object several times. Voxel-wise standard deviations of noise (μnoi se ) and
mean intensities (μsi gnal ) are estimated from those measurements and voxel-wise SNR maps
(μsi gnal/σnoi se) are constructed. However, the multiple-replica approach is not practical for
calculating SNR maps for in-vivo imaging due to patient motion and excessive measurement
time. For this reason, pseudo multiple-replica approach [41] was used instead, as it just re-
quires knowledge of the noise correlation between coils. It allows the calculation of SNR maps
from a single acquisition by mimicking the multiple replica method. First, synthetically gener-
ated random noise is scaled and correlated across coils based on the receive coil covariance
matrix. The noise covariance matrix was measured with the subject and coil setup unchanged,
by acquiring 128 readouts having 512 sampling points each, including oversampling, without
an excitation pulse. This correlated and scaled noise is injected into the data at the beginning
of the image reconstruction pipeline to produce a stack of images with different noise. The
“true” acquisition noise from the subject is still present in this synthetic data and is assumed to
be a part of the signal. From this stack of images, the voxel-wise means (μsi gnal ) and standard
deviations (σnoi se) are computed, and SNR maps (μsi gnal/σnoi se) are produced.
The SNR computations were performed for all acquired 3D MPRAGE volumes with 8 pseudo-
replicas. To improve the estimation of σnoi se , a 2D 5x5 region of neighboring pixels was used
to estimate σnoi se in a moving-average fashion according to [42].
Individual SNR maps were spatially normalized [60] to the reference ADNI-2 image volume
within the same session. Using the label maps from the reference ADNI-2 datasets, mean SNR
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values were computed for the following brain tissue types and structures: brain stem (chosen
due to its proximity to the centre of the head coil; representing the smallest expected SNR),
hippocampus, white matter (representing an average of expected SNR), and cortical grey
matter (chosen due to its proximity to the coil elements; representing the biggest expected
SNR). The differences in SNR of different protocol variants were tested with the Wilcoxon
rank-sum test [40] with Bonferroni correction for multiple comparisons [47].
SNR efﬁciency can be deﬁned as: SNR/

TA, where TA is total acquisition time. SNR efﬁ-
ciency was computed for all protocol variants and differences were tested with the Wilcoxon
rank-sum test [40] with Bonferroni correction for multiple comparisons [47].
In order to assess the contrast-to-noise ratio (CNR), data were spatially normalized [60] to
the reference ADNI-2 image volume within session. In addition to intensity normalization
performed using a scanner software-integrated pre-scan procedure, a separate B1 bias ﬁeld
correction was applied to all of the datasets [35]. This additional bias ﬁeld correction was
shown to be very robust in 3T settings. CSF, WM and GM were masked using the label masks
from the reference ADNI-2 image volumes. Two CNR values were computed as follows:
CNRcs f −gm = (μgm−μcs f )
2
(σ2cs f +σ2gm)
(4.2)
CNRgm−wm = (μwm−μgm)
2
(σ2gm+σ2wm) (4.3)
where μcs f , μgm , μwm are mean intensities and σ
2
cs f , σ
2
gm , σ
2
wm are image intensity variances
within CSF, GM and WM volumes. The differences in CNR of different protocol variants
were tested with the Wilcoxon rank-sum test [40] with Bonferroni correction for multiple
comparisons [47].
CNR efﬁciency can be deﬁned as: CNR/

TA, where TA is total acquisition time. CNR efﬁ-
ciency was computed for all of the protocols used in this study and differences were tested
with the Wilcoxon rank-sum test [40] with Bonferroni correction for multiple comparisons
[47].
It is expected that the SNR will be decreased in accelerated acquisitions when compared to
the reference ADNI-2 protocols, to a ﬁrst approximation, proportionally to the square-root of
the acceleration factor. The decrease in SNR can be attributed to the lower total acquisition
time. A further factor is the reconstruction-induced noise ampliﬁcation described by the
g-factor. Furthermore, the different protocol variants can induce a different signal modulation
in k-space.
In terms of GM-WM and CSF-GM contrast, the inversion recovery curve with the segmented
MPRAGE acquisition is mapped along the partition-encoding axis, and undersampling is
performed along the phase-encoding axis. Therefore, the resulting contrast is not expected to
change compared to the standard MPRAGE. In 2D-GRAPPA and CAIPIRINHA acquisitions,
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the inversion recovery curve is mapped mostly along the partition-encoding, and the changes
in contrast are consequently expected to be minimal [52, 61]. We expect that the changes in
CNR using accelerated acquisitions are driven by changes in noise (due to different sampling
durations between the reference and the four-fold accelerated scans) rather than by changes
in contrast. Therefore, the last part of our image processing pipeline only addresses the
noise-related effects on the results obtained with MorphoBox.
To study the noise dependency of the segmentation results, the following numerical experi-
ment was designed: scaled noise was added to the raw data of the reference ADNI-2 protocols
to mimic the SNR performance of the accelerated protocols. Based on the SNR measurements
within-session, the average SNR value was calculated between 4-fold accelerated protocols.
The level of noise added to ADNI-2 data was set to match the average SNR performance of
4-fold accelerated protocols on a per session basis. These synthetic data were reconstructed
and then passed on to the automated segmentation framework. This procedure was repeated
32 times for each subject to produce 32 synthetic image volumes and segmentation results
per subject.
The subsequently obtained volumetric results from synthetic data of the different brain struc-
tures, and tissue types were pooled from all the subjects. ICCs between synthetic volumetric
results were used as a measure of consistency of data. The model used to assess the consis-
tency of the synthetic noise experiment considered subjects to be randomly sampled from a
larger population of subjects and 32 repetitions with additional noise to be judges that are
sampled from a bigger population of judges [59]. Normalized volumetric differences between
synthetic data and the reference ADNI-2 protocol were calculated to assess whether there
is a systematic bias in the measurements. The statistical signiﬁcance of the difference in
normalized volumetric differences was tested using the Wilcoxon signed-rank test [40].
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Figure 4.2: Sample images showing representative sagittal views of all protocol variants for
3 subjects (A, B, C). Please note the increased noise level of the accelerated protocols that is
most visible in the brain stem region of the subjects.
4.4 Results
Each row in Figure 4.2 demonstrates images from the same subject (three shown in total)
obtained within one session using the reference ADNI-2 protocol and the 3-minute accelerated
protocol variants. The windowing was set to the same level for all shown images. In the brain
stem region, there is a visible increase of noise in accelerated protocols when compared to the
reference ADNI-2 protocol.
4.4.1 Observer Ratings
Figure 4.3: Observer Rankings. Relative scale
(1, best to 5, worst). * indicates signiﬁcant dif-
ference from the ADNI-2 protocol.
All raw images before noise injection were
rated by the observer as diagnostically use-
ful with high image quality (76 image vol-
umes) or mild image quality issues (34 image
volumes). Segmented MPRAGE acquisitions
exhibited, in some cases, mild ringing arte-
facts largely arising from hyper-intense sig-
nals due to abundant fat in the neck. No sys-
tematic pattern of image quality issues was
reported by the observer. Overall, qualitative
observations yield that all protocols provide
clinically useful image quality.
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Figure 4.4: Segmentation results from a single subject within one session. Blue: white matter;
Green: grey matter; Red: CSF.
The mean observer rankings (1, best to 5, worst) are shown in Figure 4.3. Note that the
3-minute CAIPIRINHA MPRAGE scans are perceived on average of identical value for radi-
ological reading as the reference 5-minute ADNI-2 scans despite a subtle, but visible noise
degradation. However, the other protocols appear statistically different (p < 0.05), as assessed
by the Wilcoxon rank-sum test.
4.4.2 Volumetric Measurements
Visually, the segmentation results from all protocols used in this study display a high degree of
similarity (Figure 4.4). The segmentation errors are at the single voxel level, and therefore hard
to visually notice. Visual inspection suggests that most of these differences occur in regions
affected by partial-volume effects. All segmentation results were visually inspected for large
segmentation errors and no gross segmentation errors have been observed in this study. It
is important to note that MorphoBox was run in a fully automated fashion and no manual
editing was applied at any stage of the segmentation process.
Intra-class correlation analysis shows highly consistent volumetric measurements of acceler-
ated protocols when compared to the reference ADNI-2 protocol (Table 4.1).
Figure 4.5 illustrates the intra-class correlation coefﬁcients between all protocols used in this
study. Each column represents an ICC between two protocol variants and each row represents
a structure. The CSF volumes in segmented MPRAGE acquisitions exhibit smaller correlation
coefﬁcients relative to the other protocol combinations. Pallidum intra-class correlation
coefﬁcients are systematically smaller than the correlation coefﬁcients of other structures.
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ADNI-2 vs.
2D-GRAPPA
ADNI-2 vs.
CAIPI
ADNI-2 vs.
Seg. MPRAGE
ADNI-2 vs.
CAIPI. Elliptical
TIV 1.00 1.00 0.99 [0.98-1.00] 1.00
Cortical Grey Matter 0.96 [0.90-0.98] 0.97 [0.93-0.99] 0.93 [0.84-0.97] 0.97 [0.92-0.99]
White Matter 0.99 [0.98-1.00] 0.99 [0.97-1.00] 0.99 [0.97-1.00] 1.00 [0.99-1.00]
Hippocampus 0.94 [0.85-0.97] 0.95 [0.88-0.98] 0.94 [0.87-0.98] 0.94 [0.86-0.97]
Thalamus 0.98 [0.94-0.99] 0.98 [0.96-0.99] 0.97 [0.93-0.99] 0.97 [0.94-0.99]
Putamen 0.96 [0.90-0.98] 0.97 [0.94-0.99] 0.95 [0.89-0.98] 0.95 [0.88-0.98]
Caudate 0.98 [0.95-0.99] 0.99 [0.97-0.99] 0.98 [0.94-0.99] 0.98 [0.94-0.99]
Pallidum 0.89 [0.76-0.95] 0.94 [0.86-0.97] 0.88 [0.74-0.95] 0.85 [0.68-0.94]
Table 4.1: Intra-class correlation coefﬁcients (95% conﬁdence interval shown in brackets).
Figure 4.5: Intra-class correlation coefﬁcients for different brain structures between all possible
protocol combinations.
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Figure 4.6 summarizes the outcome of the analysis of normalized volumetric differences when
taking computed volumes from the reference ADNI-2 protocol as a reference volume (Vr ). The
label “ADNI-2+NOISE” corresponds to a synthetic dataset generated through addition of noise
to match the SNR of accelerated protocols. There is a strong indication that the increase in
noise levels introduces a systematic bias to the computed volumes of some structures when
compared to the reference volume of the ADNI-2 protocol. Most apparent, a statistically
signiﬁcant increase in the white matter volumes in the accelerated acquisitions and a trend
towards decreased cortical grey matter volumes were observed in this investigation.
Figure 4.6: Volumetric percent difference with ADNI-2 protocol used as reference scan (Vr ).
* indicates difference from 0% median at the% signiﬁcance level. *p<10-2; **p<10-4;
Figure 4.7: Volumetric percent difference with all possible choices of reference protocol (Vr ).
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Figure 4.7 summarizes the outcome of the normalized volumetric differences analysis for all
possible choices of the reference volume (Vr ). Each column represents the outcome of com-
puting the normalized volume difference between two protocol variants used in this study and
averaging it across the subjects. The results indicate that the segmented MPRAGE acquisitions
introduce a change to estimated CSF volumes when compared to other accelerated protocol
variants.
4.4.3 Signal-to-Noise Ratio (SNR)
Figure 4.8: Voxel-wise SNR maps obtained using the pseudo multiple-replica method for a
single subject within one session.
Figure 4.8 demonstrates sagittal SNR maps computed with the pseudo multiple-replica
method [24] for a single subject within one session. Theoretically, a decrease in SNR pro-
portional to 1/

2 (reducing the acquisition time from 5 min from 3 min) is expected in the
accelerated acquisitions when compared to the reference ADNI-2 protocol. Obtained SNR
maps demonstrate the expected decrease of SNR in the accelerated protocols.
The results of the SNR analysis performed within different brain sub-structures are summa-
rized in Figure 4.9. Mean SNR values of 50 (white matter), 29 (cortical grey matter), 22 (brain
stem) and 20 (hippocampus structures) were observed, using the conventional ADNI-2 proto-
col. There is a statistically signiﬁcant drop in SNR between ADNI-2 and four-fold-accelerated
protocols. SNR dropped consistently by around 34%, 36%, 31%, and 34% for the accelerated
variants: 2D GRAPPA, CAIPIRINHA, segmented MPRAGE and CAIPIRINHA with elliptical
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Figure 4.9: SNR measurement for different brain structures and protocols. Error bars show
the standard deviations across the subjects. * indicates signiﬁcant difference between two
protocols.
scanning. White matter SNR is signiﬁcantly different between 2D-GRAPPA and segmented
MPRAGE acquisitions. The rest of the four-fold-accelerated protocols are not signiﬁcantly
different from each other.
In terms of SNR efﬁciency, Figure 4.9 illustrates performance of the protocols used in this study
and signiﬁcant differences. With the conventional ADNI-2 protocol, average SNR efﬁciency
values of 28 (white matter), 17 (cortical grey matter), 12 (brain stem) and 11 (hippocam-
pus structures) were observed. Noteworthy is a decrease in SNR efﬁciency of 2D-GRAPPA,
CAIPIRINHA, and segmented MPRAGE acquisitions in white matter, cortical grey matter and
hippocampus regions when compared to the ADNI-2 protocol. CAIPIRINHA with elliptical
scanning was not statistically different from the ADNI-2 protocol in terms of SNR efﬁciency. In
the brain stem region, only 2D-GRAPPA and CAIPIRINHA appeared to be statistically different.
On average, SNR efﬁciency decreased by 12%, 15%, 13% percent for 2D-GRAPPA, CAIPIRINHA,
and segmented MPRAGE acquisitions when compared to ADNI-2 protocol.
4.4.4 Contrast-to-Noise Ratio (CNR)
The results of the CNR assessment of all protocols used in this study are shown in Figure 4.10.
The greater the value of CNR, the better is the separation between the intensity distributions
of the tissues, which simpliﬁes the segmentation problem. Analogously to the SNR mea-
surements, contrast to noise is decreased in accelerated acquisitions. There is a statistically
signiﬁcant decrease in CNR between ADNI-2 and four-fold-accelerated protocols. On average,
CNR in the conventional ADNI-2 protocol was found to be 4.47 and 7.16 for CSF-GM and GM-
WM, respectively, which signiﬁcantly decreased on average by 29%, 26%, 38% and 28% in the
2D-GRAPPA, CAIPIRINHA, segmented MPRAGE, and elliptical CAIPIRINHA approaches. Both
CSF-GM and GM-WM CNR appears to be signiﬁcantly different between segmented MPRAGE
and other four-fold-accelerated variants. The rest of the four-fold-accelerated protocols are
not signiﬁcantly different from each other.
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Figure 4.10 illustrates CNR efﬁciency of the protocols used in this study. CNR efﬁciency in
the conventional ADNI-2 protocol was found to be 0.25 and 0.41 for CSF-GM and GM-WM.
Segmented MPRAGE appeared to be statistically different from the rest of the protocols in
terms of CSF-GM and GM-WM CNR efﬁciency. 2D-GRAPPA is statistically different from the
ADNI-2 protocol in terms of GM-WM CNR efﬁciency.
Figure 4.10: CNR averaged across subjects. Error bars indicate the standard deviations across
the subjects. * indicates signiﬁcant difference between protocols.
4.4.5 Noise Effects
Figure 4.11: Mean distance between the peaks of the intensity distributions and their variance
for the different protocol variants. * indicates signiﬁcant difference between protocols.
In order to understand whether changes in the noise or signal properties cause the observed
changes in SNR and CNR, Figure 4.11 illustrates the mean changes in the distance between
the peaks of intensity distributions of the tissues and the sum of variances of those tissues
as extracted by the MorphoBox. A statistically signiﬁcant increase in sums of variances of
σ2cs f +σ2gm and σ2wm +σ2gm between ADNI-2 and CAIPIRINHA, segmented MPRAGE, and
elliptical CAIPIRINHA acquisitions is observed. There is a statistically signiﬁcant increase in
σ2wm +σ2gm sums of variances between ADNI-2 and 2D-GRAPPA acquisitions. Both sums of
variances, σ2cs f +σ2gm and σ2wm +σ2gm appear to be signiﬁcantly different between segmented
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TIV 1.00 Thalamus 0.99 [0.99-1.00]
Cortical Grey Matter 0.98 [0.97-0.99] Putamen 0.97 [0.95-0.99]
White Matter 1.00 Caudate 0.99 [0.99-1.00]
Hippocampus 0.99 [0.98-0.99] Pallidum 0.93 [0.88-0.97]
Table 4.2: Intra-class correlation coefﬁcients (95% conﬁdence interval shown in brackets) for
the numerical experiment with addition of noise to the reference ADNI-2 scan.
MPRAGE and other four-fold-accelerated variants. Changes in the distance between the peaks
of the intensity distributions were not signiﬁcantly different.
4.4.6 Numerical experiment with addition of synthetic noise
For each subject, 32 volumes of synthetic data were computed by adding synthetic noise to
the reference ADNI-2 raw data to reduce the SNR by approximately 35%, i.e. to match the SNR
of the four-fold accelerated scans.
Table 4.2 illustrates ICCs between the segmentation results of synthetic image volumes. For
all examined structures, ICC values greater than 0.93 were observed. The estimated ICC of
pallidum volumes exhibited the smallest correlation coefﬁcient of 0.93 when compared to
other structures. Introduction of artiﬁcial 35% noise ampliﬁcation to the reference ADNI-
2 data introduced a bias in the volumetric data similar to the bias level observed with the
accelerated acquisitions (Figure 6). A statistically signiﬁcant increase in the measurements of
white matter volumes and a trend towards decreased cortical grey matter volumes are evident
when compared to the reference ADNI-2 volumes.
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4.5 Discussion
In longitudinal studies that use morphometric assessments of brain tissues and structures,
the choice of the imaging protocol can potentially inﬂuence qualitative readings and degrade
reproducibility of serial automated brain segmentations. The main objective of this study was
to investigate the impact that accelerated protocols (2D-GRAPPA, CAIPIRINHA, segmented
MPRAGE, andCAIPIRINHAwith elliptical scanning) have on the observer’s qualitative readings
and on an automated brain segmentation procedure.
Qualitative analysis demonstrated that all of the data obtained using the accelerated 3-minute
protocols have clinical value, even if artefacts are present and despite the changes in noise
distribution. This observation can be explained by the fact that radiologists are used to
“reading through” artefacts and indicates that, in these settings (3T with a 32-channel head
coil), the “gold-standard” reference ADNI-2 protocol provides an SNR value that is sufﬁciently
high. It is important to note that the radiological readings of the CAIPIRINHA scans were
perceived to provide on average the same diagnostic image quality as the reference ADNI-2
scans despite a 36% reduction in SNR. This may further indicate that the images obtained with
the conventional ADNI-2 protocol using a 32-channel coil operate in an SNR regime and/or
have the artefact-to-noise ratio that provides an image quality beyond the minimum routine
reading requirements. Also, the shorter scan time can reduce motion sensitivity and may lead
on average in the longer scans to some subtle degradation of the overall image quality.
However, when volumetric data acquired with different protocols are pooled in longitudinal
studies, one has to be cautious of potentially introducing a bias to any quantitative analysis.
In our analysis, we found such a bias of the order of 2% in white matter and of the order of 1 %
in cortical grey matter volumes when using the accelerated protocols.
If we look at the speciﬁc structures, for instance, we found that the hippocampus volume
assessment differs most when comparing the reference ADNI-2 standard with the segmented
MPRAGE and CAIPIRINHA with elliptical-scanning acquisition protocols. Pallidum volumes
were most affected by 2D-GRAPPA and caudate volumes were most affected by segmented
MPRAGE when compared to the reference ADNI-2 protocol.
Overall, the most consistent accelerated acquisition scheme for morphological analysis when
compared to the reference ADNI-2 protocol is CAIPIRINHA, since the systematic changes
in volumes that were observed are the smallest and a strong correlation between volumes
is present. However, this MPRAGE variant can only be applied in the situations when multi-
channel coils are used and if there is a sufﬁcient variation in coil sensitivity proﬁles.
For small structures, the observed changes in volumes segmented by MorphoBox were con-
sistent with the results presented in several reproducibility studies [21, 23, 25, 26] comparing
repeat scans with an identical protocol. In particular, if we recomputed our normalized vol-
umetric differences between the CAIPIRINHA and the reference ADNI-2 protocol using the
methodology described in [21] we observed: hippocampus 2.65 +/- 1.45 %; caudate 1.57 +/-
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1.25 %; pallidum 1.45 +/- 1.35 %; putamen 1.63 +/- 1.03 %; thalamus 1.35 +/-1.16 %. Those
values are in agreement with values reported in a reproducibility study [21] processed with the
FreeSurfer [62, 63] software package (version 5.1.0): hippocampus 3.26 +/- 0.93 %; caudate
2.57 +/- 0.36 %; pallidum 7.44 +/- 1.95 %; putamen 4.61 +/- 0.88 %; thalamus 4.97 +/-1.29
%. Slightly smaller absolute normalized volumetric differences in the current study can be
attributed to the use of a single scanner platform, not repositioning the subject within the
session, time span between scan and rescan, hydration level changes, different degree of
acceleration, different types of accelerations, different age group, smaller subject number, and
may also be attributed to the differences in the segmentation software.
ICCs between the reference ADNI-2 protocol and the respective accelerated variants were
also similar to previously reported values in reproducibility studies [21, 25, 27], comparing
repeat scans with an identical protocol. In particular, the correlations of volumes of small
structures from CAIPIRINHA and reference ADNI-2 protocols are comparable to the values
reported in [27] processed with FreeSurfer [62, 63] (version 4.0.1): hippocampus 0.95 [0.88-
0.98] (this work) vs 0.989 [0.976-0.997] [27], caudate 0.98 [0.95-0.99] vs 0.994 [0.988-0.998],
pallidum 0.88 [0.74-0.95] vs 0.706 [0.445-0.897], putamen 0.97 [0.94-0.99] vs 0.971 [0.939-
0.991], thalamus 0.98 [0.96-0.99] vs 0.984 [0.965-0.995]; numbers in brackets represent the 95%
conﬁdence intervals. The differences in ICCs are small and can be attributed to the bigger
subject number and slightly different protocol parameters (TR/TI/TE/ﬂip angle) in the current
study as well as different scanner platform, not repositioning the subject within the session,
time span between scan and rescan, hydration level changes, different degree of acceleration
and different segmentation software.
Considering other possible protocol combinations, the most interchangeable protocol com-
binations are CAIPIRINHA / 2D-GRAPPA and CAIPIRINHA / CAIPIRINHA with elliptical
scanning. This conclusion is based on the observed high ICC values and small changes in
volumes relative to the other protocol combinations (Figure 4.5, Figure 4.7). There is a strong
indication that segmented MPRAGE acquisitions introduce a change to CSF volumes. These
differences can be attributed to the reduction in susceptibility-related distortions due to the
increased bandwidth. Qualitatively, it can be observed that there is a better delineation of CSF
in segmented MPRAGE acquisitions. We assume that this MPRAGE variant exhibits similar
properties as the multi-echo MPRAGE variant MEMPRAGE [64].
The CNR and SNR analysis performed in this study depends on segmentation quality of
MorphoBox and the accuracy of the registration algorithm. An alternative option would be
to perform brain tissue segmentations manually. However, manual segmentations would be
vulnerable to human error and are very time consuming. Another alternative option would be
to not fully segment brain tissues but rather select small ROIs within them. However, using
this method for SNR and CNR analysis will not necessarily capture the noise ampliﬁcation
(g-factor).
In order to assess the segmentation errors made by MorphoBox, it would be ideal to have the
44
4.5. Discussion
ground truth segmentations. However, no brain segmentation method, be it automatic or
manual, is error-free. Experimentally, MorphoBox and FreeSurfer [62, 63] segmentation tools
have been compared on the ADNI [16] database in terms of disease detection accuracy and
showed that MorphoBox and FreeSurfer achieve similar performance levels [12]. In the current
study, no gross segmentation errors were observed in all of the acquired image volumes and
the differences were at the single voxel level. Visually, most of these differences occurred in
regions affected by partial volume effects. Potential segmentation errors can be a consequence
of partial volume effects since they make the segmentation problem intrinsically ambiguous
and CNR/SNR changes can amplify this ambiguity. An indication of this effect is given by the
order of magnitude of the observed differences in volumes between the protocol variants,
suggesting that only a small number of voxels are affected.
The SNR analysis yielded approximately a 1/

2 decrease in SNR when moving from the accel-
erated reference ADNI-2 protocol to further accelerated variants. This result is expected from
theoretical considerations when assuming that noise is proportional to
√
sampling time
[65]. In 2D-GRAPPA, CAIPIRINHA and CAIPIRINHA with elliptical-scanning acquisitions,
the reduced sampling time, and thus the decrease in SNR, is attributed to undersampling of
k-space. The small difference to the theoretically expected value indicates a negligible addi-
tional g-factor penalty. In segmented MPRAGE, the decrease in SNR is due to the increased
bandwidth.
The SNR efﬁciency of 2D-GRAPPA, CAIPIRINHA, and segmented MPRAGE acquisitions de-
creased compared to the ADNI-2 protocol. This can be attributed to prolonged fraction of scan
time as a result of the acquisition of reference lines in these protocol variants. CAIPIRINHA
with elliptical scanning was not statistically different from the ADNI-2 protocol due to reduced
scan time and increased SNR because of the use of elliptical scanning.
Systematic changes in the CNR were observed in the accelerated acquisitions. The analysis
of the means and variances of intensities of the accelerated protocols revealed that there is
a systematic change in the noise ﬁgure compared to the reference protocol. This change in
variance is largely explained by the observed changes in SNR of the accelerated acquisitions.
It is important to note that the changes in SNR and CNR can also potentially inﬂuence the
scan-rescan reproducibility of the four-fold-accelerated protocols in terms of segmentation
results. Even though, a recent study [22] demonstrated negligible impact on the test-retest
reproducibility within identical protocols, with our current experimental design, we are unable
to fully address scan-rescan reproducibility of the four-fold-accelerated protocols and further
research is needed. Therefore caution must be exercised when using the four-fold-accelerated
protocols in research or clinical settings for volumetric analysis.
In the numerical experiment that added synthetic noise to the reference ADNI-2 data, there
is a high degree of consistency between the segmentation results of synthetic data within
a subject. This conclusion is based on the high ICC values for all considered structures. In
terms of volumetric results, the synthetically noise-matched ADNI-2 scans and the accelerated
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protocols exhibited similar bias when compared to the reference ADNI-2 protocol. Although
the results suggest that noise properties affect volume bias, it should be noted that the exact
relationship between noise and volume biases and the impact of other sources of biases
cannot be disentangled by the current study design.
Overall, our analysis of the inﬂuence of noise on the segmentation results suggests that, in
contrast to other reproducibility studies, inconsistencies between scans can be at least partly
explained by the noise, CNR, and SNR – values which are measureable in dedicated settings. In
other words, we hypothesize that it may be possible to correct for those systematic changes in
the volumetric assessments of brain structures based on the knowledge of the noise level in the
image. This statement is based on our experimental observations of volumetric measurements
with high ICC values between protocol variants and the presence of a systematic bias.
However, further investigation is needed to generalize these ﬁndings, i.e. to determine if it is
possible to extrapolate the ﬁndings to different coil setup, scanner ﬁeld-strength, acquisition
time, resolution, scan orientation and other parameters that may result in different levels of
partial volume contamination and different SNR/CNR levels.
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In summary, there are three main practical results of this study. First, accelerations of 3D
structural brain scans beyond the routinely used acceleration factor of two have a measureable
impact on some image analysis metrics (CNR, SNR, and noise). However, obtained images
provide at least very similar information for qualitative readings in this 3T setting. Second, our
analysis suggests that using or combining data from different variants of MPRAGE protocols
should be done with caution. This statement is based on the ﬁndings of a number of quantita-
tive image analysis metrics including SNR, CNR and volumetric assessments that all showed
differences between the variants. This holds especially true for small brain structures that
are subject to higher partial-volume effects than larger structures. Third, our results suggest
that volumetric biases (at least under the given study conditions and subject to limitations
mentioned in discussion) are largely affected by the noise properties of the images.
Overall, one has to carefully consider the exact use case of the accelerated protocols. In some
situations, the beneﬁts of using such accelerated protocols may potentially outweigh the
drawbacks. For example, the management of patient motion is expected to improve through
the use of accelerated protocols. In our study, it was demonstrated that accelerated protocols
may be used in routine clinical readings. An indicator of this statement is given by the results
of the qualitative readings that ﬁnd the reference ADNI-2 and the CAIPIRINHA scans to have
equal image quality based on qualitative assessment. We provide an error estimate on the
volumetric results, when accelerated protocols are used and compared to a “standardized”
ADNI-2 protocol. Therefore, if quantitative volumetric assessment is of interest, a careful
consideration must be given to the effect size of changes in volumes for the structure of
interest when using data from accelerated protocols. The future direction of this study will
be to investigate scaling procedures as a feasible way to correct for inconsistencies in the
accelerated protocols.
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5 Correction and optimization strate-
gies towards reliable and robust esti-
mation of data elements
The primary objective of this chapter is to investigate the applicability of scaling procedures as
a means to compensate for discrepancies between hardware setups, and protocols observed
in Chapters 3 and 4. Data collected as part of the studies described in Chapters 3, 4 and
an additional set of data collected as a part of ADNI initiative are considered in the present
chapter. Current state-of-the-art protocol-based approaches are investigated and compared
to the proposed image-property-based approach.
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5.1 Introduction
In the analysis of different acquisition scenarios used for volumetric assessment in Chapter 4,
we observed discrepancies between morphometric data acquired with different protocols on
the same system with the same resolution (1mm x 1mm x 1mm). We varied the acquisition
time at the expense of both contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR)
which resulted in systematic biases in volumes of most notably grey matter (GM) and white
matter (WM) structures.
In Chapter 3, we investigated the scenario under which the SNR matched protocols were
used on different MR scanner models. Several scanning scenarios were analysed: a) back-to-
back scan-rescan; b) repositioning; c) 2 week gap between scan and rescan. Both b) and c)
acquisition scenarios were shown to be largely negligible compared to scan-rescan variability.
Acquisition protocols of systems with different ﬁeld strength were adjusted according to ADNI
guidelines [17, 16] in order to provide similar SNR performance across the ﬁeld strengths. The
most notable difference between the 1.5T and 3T protocol parameters was the voxel volume
(1mm x 1mm x 1mm vs. 1.25mm x 1.25mm x 1.2mm). Despite the similar SNR between
1.5T and 3T protocols, differences in contrast-to-noise ratio were observed. Also, differences
in volumes of all of the investigated structures were observed between either protocols or
systems.
Without the use of any sophisticated correction strategies as discussed in the further scope of
this work, our ﬁndings indicate that the best reproducibility is achieved when the same system
and protocol are used. This has important implications in the context of both research study
designs and clinical workﬂows. For instance, a recent meta-analysis by Frisoni et al. includes 9
investigations addressing the rate of hippocampal atrophy in a total of 645 Alzheimer’s disease
(AD) patients and 348 controls [8]. The average rate of atrophy per year was 2.9-5.6%, mean
4.25% in AD and 0.3-2.2%, mean 1.25% in controls, which results in an average difference of 3%
atrophy per year between AD versus controls. This means that the methodological variability
should be less than 3% if baseline and follow-up investigations are done in an interval of 1 year.
This highlights that both changes associated to normal aging and AD or mildly cognitively
impaired(MCI) are small and further motivates the need to remove the effects that might
confound the analysis.
However, in practice it is not always possible to perform the measurements on the same
system both in the single centre settings and especially in the multi-center settings. Moreover,
with uncooperative patients, the acquisition time can be a limiting factor making it difﬁcult
to keep the protocol parameters consistent. Allowing the use of different systems and the
ﬂexibility in protocol parameters can drastically accelerate the collection of data and result in
an increase of statistical power by virtue of having a greater number of subjects. This increase
in statistical power can allow detection of morphometric changes with greater precision in
both cross-sectional and longitudinal studies.
The purpose of this chapter is to investigate correction strategies for the systematic biases
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present in brain volumetric measurements due to heterogeneous acquisition systems and
protocols. The current state-of-the-art approaches, propose to either remove the unwanted
technological variability through preprocessing of the input data[66, 67] or to scale the vol-
umes obtained with the automated segmentation software to a reference value based on the
knowledge of the protocol[45, 68].
The use of protocol-based correction strategies has several drawbacks. First, a separate cali-
bration study needs to be carried out whenever a new protocol, system, or site are introduced.
Second, caution must be exercised when applying protocol-based compensation strategies to
subjects that undergo changes in contrast due to disease, aging or other not system or protocol
related factors. For instance, it has been reported that that there is a decrease in T1-weighted
contrast that is attributed to aging [69]. These changes in contrast can potentially confound
the segmentation results due to partial volume effects and bias the estimated effect of aging,
disease, or treatment.
To address these problems a novel image-property-based approach of scaling the data to
the same reference level is developed and proposed in this thesis. It is compared to the
state-of-the-art protocol-based approaches.
5.2 Materials and Methods
5.2.1 Acquisition
We had access to three datasets acquired under an IRB-approved protocol that contained 3D
T1-weighted MPRAGE acquisitions.
Bonn dataset
This dataset consists of 22 healthy young subjects (20-44 years old). The experimental design
and acquisition parameters are described inChapter 4. The voxel sizewasmaintained constant
but the scan time was varied at the expense of SNR and CNR.
Basel dataset
This dataset consisted of 22 healthy young subjects (20-39 years old). The experimental design
and acquisition parameters are described in Chapter 3. Note that unlike the Bonn dataset,
the voxel size was adjusted to maintain the same SNR levels across the systems. In Chapter
3, we observed changes in CNR between data acquired at different ﬁeld strengths. However,
those changes are correlated to the changes in voxel size making it difﬁcult to extrapolate the
changes observed in the Bonn dataset to the current one.
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ADNI dataset
This multi-centre dataset consists of screening (1.5T)/baseline (3T) T1-weighted MPRAGE
acquisitions. Clinical status (healthy, mildly cognitively impaired(MCI) or Alzheimer(AD)),
age, gender parameters were available as a part of this database for each subject. To mitigate
hardware effects, our analysis was restricted to the 335 subjects (54-91 years old) who were
scanned on systems of one vendor (Siemens Healthcare, Germany) only. Within these subjects,
95 were healthy, 166 were MCI, and 166 were AD. Each subject had two screening scans
acquired at 1.5T without repositioning with a voxel size of 1.25×1.25×1.2 mm3. A fraction of 45
subjects also had two consecutive baseline scans at 3T with a voxel size 1×1×1.2 mm3 (roughly
SNR-matched to the 1.5T data). Note that similarly to the Basel dataset, the ﬁeld strength is
strongly correlated to the voxel size.
Interpolated Basel dataset
The slice thickness used in 3T ADNI protocol [17] differs from the 3T protocol used in the
acquisition of the Basel dataset(1mm vs 1.2mm).
To investigate if we can apply the correction strategies learned from the Basel data set to the
ADNI dataset, the raw k-space data(which was stored during the study) from all 3T Basel
datasets was cropped to match the resolution of the 3T ADNI protocols(1.2mm slice thickness)
and retrospectively reconstructed on the scanner.
Combined dataset
This dataset consisted of both the interpolated Basel and the ADNI datasets.
5.2.2 Data Processing
Automated segmentation
All scans were processed using the MorphoBox prototype [12] to estimate the volumes of total
gray matter (GM), total white matter (WM), total cerebrospinal ﬂuid (CSF), total normalized
brain volume(NBV), hippocampus, thalamus, putamen, caudate, and pallidum structures.
CNR assessment
The CNR of all image volumes was quantitatively assessed using the label maps provided by
MorphoBox. The methodology used to assess the CNR is described in Chapter 3.
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5.2.3 Statistical analysis
In Chapter 3 a linear mixed effect mixed model was used to detect the differences between the
acquisition systems. However once the model is ﬁt, it is possible to use it to make predictions
about previously unseen data. In this section two models that were used to make predictions
to scale volumetric data to the same reference are outlined.
Protocol-based compensation strategy
First, we examined a simple model which considered that the main parameter that deﬁnes the
differences between the outcomes of two consecutive automatic brain volume segmentations
with-in a subject is the protocol type.
For each structure of interest, a linear mixed-effect model[44]:
y = Xβ+Zγ+
 (5.1)
was ﬁt on the estimated volumes normalized by total intracranial volume and logarithmically
transformed. The purpose of the logarithmic transform is to warrant that volumes predicted
by the linear mixed-effect model are always positive. In this model, protocol type, age, sex,
and clinical status(healthy, MCI or AD) were modelled as ﬁxed effects (X ). Random effects
consisted only of subject-dependent offsets (Z ). β and γ were regression coefﬁcients that
represent the ﬁxed and random effects. Mathematically, the main difference between regres-
sion coefﬁcients is that βwas modelled as a ﬁxed parameter and γ as a random variable. The
residual error 
 represented the scan-rescan variability.
Image-property-based compensation strategy
There are various factors that can potentially affect the outcomes of the morphometric assess-
ment (SNR, CNR, voxel-size, blurring, ghosting, ringing, etc). In this part of the experiment we
focused on the CNR and voxel-size parameters. Blurring, ghosting and ringing were assumed
being negligible as all data were found of high image quality based on visual inspection and
automated quality control [70]. With the protocol-based correction strategies, we implicitly
assumed that we can capture the changes with just one parameter, namely the system/proto-
col identiﬁer. However, there are changes in contrast that are attributed to normal aging [69].
In Chapter 4, we observed that both CNR and SNR can potentially affect the outcome of an
automatic brain segmentation. Therefore, we propose a slightly more complex model of the
similar form as Equation 5.1 that aims to explain the discrepancies in volumetric observations
with-in a subject purely based on the voxel volume, and the contrast-to-noise ratio.
For each structure of interest, a linear mixed-effect model was ﬁt to the sequence of volumes
normalized by TIV after logarithmic transformation with clinical status (healthy, MCI or AD),
subjects age, voxel volume, and CNR normalized by voxel volume treated as ﬁxed effects (X),
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and the subject identiﬁer treated as a random effect (Z) in order to account for the repetition
of measurements within subjects. The normalization of CNR by voxel volume was performed
in order to mitigate the correlation of CNR and voxel volume.
Evaluation of compensation strategies
All models were ﬁt with the R software (version 3.1.1) using the lme4 package [44] on each
dataset separately. First, we looked at the regression coefﬁcients produced by each model. The
Satterthwate’s approximation was employed to estimate the number of degrees of freedom
using the lmerTest package [46], and generalized t-tests were used to test the signiﬁcance of
the regression coefﬁcients. The regression coefﬁcients were plotted for each dataset separately.
All datasets were ﬁrst examined separately using a leave-one-out cross validation. The ﬁtted
model parameters were used to correct volumes for ﬁxed effects so as to match the arbitrary
reference of a healthy subject scanned at 3T with ADNI protocol parameters.
However, an important question that needs to be answered is how generalizable are our
ﬁndings. To answer this question, we would need both a training and a test dataset. We can
consider ADNI and Basel databases to be as training and testing datasets and vice-versa. Since
there are differences in resolution between the ADNI and Basel imaging protocols (1.2mm
vs. 1mm slice thickness) we used the interpolated data from the Basel dataset for this part of
the experiment. It is important to point out that the subjects in the ADNI database were old
and there were diseased subjects in contrast to Basel dataset where there were only young and
healthy subjects. Note that there is a strong correlation between voxel size and CNR. However,
if our testing dataset is sampled in the same way as the training dataset, this co-linearity
should not affect the predictive power of the model.
To study if the observed differences were due to insufﬁcient sample size, data were combined
into a combined dataset that consisted of the interpolated Basel and the ADNI datasets, and a
leave-one-out cross validation on combined dataset was performed.
In order to assess the performance of each correction strategy within one subject, relative
volume differences (RVD) were computed between all possible combinations of acquired data
as:
RV D = |V1−V2|
V1+V2
(5.2)
where V1 and V2 were brain volume estimates.
Normalized histograms were constructed for both corrected and uncorrected data.
Finally, to obtain further insight into age dependent effects, we performed the following
bootstrap procedure. We randomly drew a sample of 20 subjects from the combined dataset
to train the model and 20 subjects to test the model. This procedure was repeated varying the
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percentage of subjects from ADNI datasets from 0-100% with a step of 10% for the training
dataset and 20 subjects would be selected randomly from the remaining subjects at each step.
The mean difference between adjusted and unadjusted RVDs was plotted as a function of the
training database age and testing database age.
5.3 Results
5.3.1 Protocol-based compensation strategies
Figure 5.1: Regression coefﬁcient for protocol-based model ﬁt separately for each structure on
ADNI, Basel, interploated Basel, and combined datasets. Error bars indicate 95% conﬁdence
interval computed via boot strap with 500 simulations. * p<0.05; ** p<10-2; *** p<10-3;
First, the effects of protocol-based correction strategy were examined. Regression coefﬁcients
for ADNI, Basel, combined, and interpolated BASEL datasets are plotted in Figure 5.1. Note
that the direction of the ﬁeld strength effect is consistent for all structures except for CSF and
putamen. The magnitude of the effect is notably smaller with the interpolated Basel dataset
compared to the ADNI dataset except for thalamus and palladium structures.
The leave-one-out cross validation results for the model trained on the ADNI dataset are illus-
trated in Figure 5.2, Table A.3. Comparison of distributions of errors for corrected/uncorrected
1.5T and 3T protocols showed a notable decrease in mean RVDs for all of the evaluated struc-
tures except for the putamen after applying the protocol-based correction strategy. However,
note that for all of the investigated brain structures, RVDs were still larger on the average than
the scan-rescan variability (illustrated in green) after the application of the protocol-based
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Figure 5.2: Distributions of relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T
(pure scan-rescan variability) of ADNI dataset with protocol-based compensation strategy
computed in leave-one-out cross-validation settings
correction strategy.
When a leave-one-out cross validationwas performed on the interpolated Basel dataset (Figure
5.3, Table A.4), there was a decrease in mean RVDs of: WM, thalamus, pallidum, caudate, and
hippocampus structures when volumetric data were scaled to the same reference. There were
only small changes to the distribution of errors in volumes of GM, CSF, NBV, and putamen
structures compared to unadjusted data. It is noteworthy that the mean unadjusted RVDs
are smaller with the interpolated Basel dataset(Table A.4) compared to ADNI dataset (Table
A.3) and are very close to the distribution of scan-rescan RVDs for CSF, NBV, and putamen
structures.
Figure 5.4, and Table A.5 illustrate the results of leave-one-out cross validation of the model
ﬁt on Bonn dataset. There was a notable decrease in mean RVDs of WM structure when
accelerated protocols are scaled to match the ADNI-2 reference protocol (Table A.5). The
distribution of errors in volumes for other structures did not change signiﬁcantly. Note that
due to the study design, the scan-rescan errors are not available.
When the model used to correct for protocol differences was trained on the ADNI dataset
and the volumes from the interpolated Basel dataset were scaled to the same reference value,
there was a noticeable increase in protocol discrepancies for GM(Mean RVD 0.01(original)
vs 0.03(adjusted)), CSF(Mean RVD 0.02 vs 0.04), and NBV(Mean RVD 0.005 vs 0.01) volumes.
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Figure 5.3: Distributions of relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T
(pure scan-rescan variability) of interpolated Basel dataset with protocol-based compensation
strategy computed in leave-one-out cross-validation settings
Figure 5.4: Distributions of relative volume differences ADNI-2/accelerated protocols (Ad-
justed, Original) of Bonn dataset with protocol-based compensation strategy computed in
leave-one-out cross-validation settings
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Figure 5.5: Distributions of relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T
(pure scan-rescan variability) of interpolated Basel dataset with protocol-based compensa-
tion strategy computed when the model is trained on ADNI dataset and applied to scale
interpolated Basel dataset
However, mean RVDs between 1.5T and 3T protocols of WM, thalamus, caudate, pallidum
improved compared to unadjusted data(Figure 5.5, Table A.6). The improvement in mean
RVDs for thalamus is the most striking. No changes were observed in mean RVDs of putamen.
Training correction model on the interpolated Basel dataset and scaling the volumes from
the ADNI dataset to the same reference value resulted in a noticeable improvement in mean
RVDs (Figure 5.6, Table A.7) of all structures except the CSF and putamen. However, these
improvements were rather modest compared to the improvements observed during leave-
one-out cross validation and the scan-rescan variability of 3T data.
When both ADNI and interpolated Basel datasets were combined into a combined dataset
and leave-one-out cross-validation procedure was performed (Figure 5.7), there was an
improvement in discrepancies in volumes for all structures. On a subset of interpolated Basel
dataset, the discrepancies in both CSF and GM were smaller than when the same model was
trained on ADNI database and interpolated Basel data was scaled to reference value. However
overall, it should be noted that the improvements were rather modest in comparison with the
scan-rescan variability of 3T-3T data for both datasets with an exception of thalamus structure.
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Figure 5.6: Distributions of relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T
(pure scan-rescan variability) of ADNI dataset with protocol-based compensation strategy
computed when the model is trained on interpolated Basel dataset and applied to scale ADNI
dataset
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Figure 5.7: Distributions of relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T
(pure scan-rescan variability) of combined dataset with protocol-based compensation strategy
computed in leave-one-out cross-validation settings. ADNI and Interpolated Basel datasets
are shown separately.
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5.3.2 Image-property-based compensation strategy
Figure 5.8: Regression coefﬁcient for CNR, and voxel volume effects ﬁt separately for each
structure on ADNI, Basel, interpolated Basel, and combined datasets. Error bars indicate 95%
conﬁdence interval computed via boot strap with 500 simulations. * p<0.05; ** p<10-2; ***
p<10-3;
Figure 5.8 shows regression coefﬁcients of the model that considered CNR and voxel volume
as factors deﬁning the outcome of automated brain volume segmentation. The model was
trained on the ADNI, BASEL, combined, and interpolated Basel datasets. Note that due to the
presence of correlation between CNR and voxel volume, the conﬁdence intervals were rather
large.
The results of leave-one-out cross-validation were similar to the protocol-based correction
strategy for both ADNI (Figure 5.9, Table A.10) and interpolated Basel (Figure 5.10, Table
A.11) datasets. It is important to note that the 3T scan-rescan distributions of errors did not
change signiﬁcantly after the application of the image-property-based compensation strategy.
The outcome of leave-one-out cross validation performed on a Bonn dataset was similar to the
one of protocol-based compensation strategy resulting in a notable decrease in discrepancies
in volumes of WM structure (Figure 5.11, Table 1 A.12).
When the image-property-based model was trained on ADNI dataset and volumes from
interpolated Basel dataset were adjusted to match a 3T reference (Figure 5.12, Table A.13),
there was a notable decrease in mean RVDs for WM, thalamus, caudate and pallidum (Table
A.13). No changes in mean RVD of hippocampus were observed. However, discrepancies in
volumes of GM, and CSF structures were increased compared to original values. Note that this
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Figure 5.9: Distributions of relative volume differences(Adjusted, Original) 1.5T/3T and 3T/3T
of ADNI dataset with image-property-based compensation strategy computed in leave-one-
out cross-validation settings
Figure 5.10: Distributions of relative volume differences(Adjusted, Original) 1.5T/3T and 3T/3T
of interpolated Basel dataset with image-property-based compensation strategy computed in
leave-one-out cross-validation settings
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Figure 5.11: Distributions of relative volume differences ADNI-2/accerated protocols (Ad-
justed, Original) of Bonn dataset with image-property-based compensation strategy computed
in leave-one-out cross-validation settings
increase is smaller than the one of a purely protocol-based compensation strategy.
Figure 5.13, and Table A.14 illustrate the case when the image-property-based model was
trained on interpolated Basel dataset and volumes from ADNI dataset were adjusted to the
same reference. There was an improvement for all structures except putamen and pallidum.
The reduction in discrepancies of volume estimates between 1.5T - 3T protocols when image-
property-based correction strategywas appliedwas greater compared to purely protocol-based
approach most notably for volumes of WM, and GM structures.
When both ADNI and interpolated Basel datasets were combined into a combined dataset
and a leave-one-out cross-validation procedure was performed, there was an improvement in
correcting both the interpolated Basel and the ADNI datasets (Figure 5.14, Table A.15, Table
A.16). The discrepancies in both CSF and GM were smaller than when the image-property-
based model was trained on ADNI database.
Overall, the image-property-based correction strategy performed considerably better than
the protocol-based strategy most notable reducing the discrepancies between 1.5T and 3T
protocols in the case of WM, GM, and CSF structures as illustrated by Figure 5.7 and Figure
5.14.
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Figure 5.12: Distributions of relative volume differences (Adjusted, Original) between 1.5T/3T
and 3T/3T of interpolated Basel dataset with image-property-based compensation strategy
trained on ADNI dataset
Figure 5.13: Distributions of relative volume differences (Adjusted, Original) between 1.5T/3T
and 3T/3T of ADNI dataset with image-property-based compensation strategy trained on
interpolated Basel dataset
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Figure 5.14: Distributions of relative volume differences (Adjusted, Original) 1.5T/3T and
3T/3T of combined dataset with image-property-based compensation strategy computed
in leave-one-out cross-validation settings. ADNI and Interpolated Basel datasets are shown
separately.
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Figure 5.15: Bootstrap validation of protocol-based compensation strategy. Testing database
age is plotted on the y-axis and training database age is plotted on the x-axis. Colour represents
the difference in mean RVDs of adjusted and unadjusted data.
5.3.3 Bootstrap
The results of bootstrap procedure that investigated the applicability of both image-property-
based and protocol-based models are illustrated in Figure 5.15 and Figure 5.16. The y-axis
represents the age of the testing datasets and x-axis represents the age of training datasets.
Each rectangle represents one bootstrap run. The size of the rectangle in each dimension is 2
standard deviations of the subjects age and the centre is the mean age of subjects for training
and testing datasets. The colour represents the difference in the mean RVDs between adjusted
and unadjusted data. Red colour indicates the increase in 1.5T-3T discrepancies and green
indicates decrease.
The protocol-based compensation strategy ampliﬁed the discrepancies between 1.5T and
3T protocols when the age range of training and testing datasets differed (Figure 5.15). The
results conﬁrm our initial observations that when the model is trained on ADNI dataset and
interpolated Basel datawas scaled to a reference value (Figure 5.5) there was a notable increase
in differences between 1.5T-3T protocols for GM, CSF structures. The modest improvement in
differences between 1.5 T - 3 T data for GM and CSF structures was observed when the model
was trained on young subjects and old subjects were used to test the model, as was previously
observed when the model was trained on interpolated Basel dataset and the data from ADNI
dataset was corrected (Figure 5.6).
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Figure 5.16: Bootstrap validation of image-property-based compensation strategy. Testing
database age is plotted on the y-axis and training database age is plotted on the x-axis. Colour
represents the difference in mean RVDs of adjusted and unadjusted data.
The image-property-based compensation strategy was more robust with respect to the choice
of the age range for both training and testing datasets regarding discrepancies between 1.5T
and 3T protocols(Figure 5.16) when compared to the protocol-based compensation strat-
egy(Figure 5.15). The modest increase in 1.5T-3T protocol discrepancies when old subjects
were used to train the model and young subjects were used to test conﬁrmed our initial in-
vestigation of training the model on ADNI dataset and scaling interpolated Basel data to a
reference value (Figure 5.12) . There was a noticeable improvement in differences between the
protocols for WM and CSF structures when the model was trained on young subjects and the
volumes from old subjects were corrected similar to previously investigated scenario when the
model is trained on interpolated Basel data and ADNI data is scaled to reference value(Figure
5.13).
5.4 Discussion
In this work, we investigated several approaches to scale multi-protocol and multi-scanner
volumetric data to a reference value. A protocol-based compensation strategy was compared
with an image-property-based compensation strategy on four datasets: Bonn dataset (the
same system with different protocols that modulate CNR keeping voxel volume constant),
Basel dataset (different systems, different protocols between ﬁeld strength), ADNI dataset
(different systems, different protocols between ﬁeld strength), and combined dataset (ADNI
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and interpolated Basel dataset).
The protocol-based leave-one-out validations performed well on each individual dataset as
illustrated in Figure 5.2, Figure 5.3, and Figure 5.15. Results obtained using the MorphoBox
prototype conﬁrmed the feasibility of scaling morphemetric data to a reference value purely
based on the protocol information as previously reported using both FSL and FreeSurfer
segmentation tools[45, 68].
With a protocol-based approach, if we focus on correcting differences between the 1.5T and
3T protocols then when scaling factors were learned using the ADNI dataset and applied to
interpolated Basel dataset, the systematic bias in volumes of GM and CSF structures was
increased (Figure 5.5).
To obtain further insight into these discrepancies, regression coefﬁcients (Figure 5.1) of the
same model ﬁt separately on both ADNI and Basel datasets were examined. The regression
coefﬁcients were drastically different for GM and CSF structures. There are several possible
sources for these discrepancies:
(a) Age of the subjects is different (old vs. young)
(b) 3T interpolated Basel data was acquired using new high-channel head coils while the
ADNI data was acquired using older hardware
It is important to note that changes in image contrast associated with ageing have been
previously reported [69]. The CNR measured on both ADNI and interpolated Basel datasets
conﬁrms previously reported changes in contrast. The decreased contrast makes the tissue
segmentation problem more difﬁcult and therefore leads to the higher discrepancies in volume
measurements. Therefore, there is an indication that these age-dependent CNR changes can
result in age-dependent biases in brain volume estimates.
When leave-one-out cross validation was performed on a combined dataset, the systematic
biases were decreased. However, differences were still considerable when compared to the
scan-rescan variability. In case of volumes of GM and CSF structures, regression coefﬁcients
in Figure 5.1 highlight that when the protocol-based model was ﬁt on a combined dataset
it resulted in a compromise between models ﬁt separately on both ADNI and Basel datasets.
While this leads to an overall decrease in the systematic biases, it does not yield optimal
performance when ADNI and Basel datasets are examined separately (Figure 5.7).
In practice, all these ﬁndings indicate that it is difﬁcult to generalize the protocol-based
compensation strategies to different age groups and possibly systems. This means that for
new age groups, protocols, and systems a separate calibration study would need to be carried
out. This may be very costly and often not possible in a real-world scenarios.
Image-property-based compensation strategies have a potential to relax this condition since
they would require only one calibration study to be performed. This strategy assumes that the
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main factors deﬁning the outcome of morphometric assessments are CNR and voxel volume.
For instance, if the calibration study involved a sufﬁcient range of CNR and voxel volume
parameter settings than when a new protocol is introduced the effects on morphometry can be
extrapolated without the need of performing a separate calibration study. Prior to interpreta-
tion of the results, it should be noted that in the current analysis there was a strong correlation
between the CNR values and voxel size in the three datasets(ADNI,Basel, Combined) due to
the study designs, i.e. the voxel size adjustment between protocols at different ﬁeld strengths
in order to match the SNR.
Due to the presence of this colinearity, we can only perform the following tests:
(a) Leave-one-out cross validation on each individual dataset (ADNI, Basel, Bonn)
(b) Leave-one-out cross validation the combined dataset (ADNI + interpolated Basel)
(c) Train on ADNI dataset and scale volumes of interpolated Basel dataset to a reference
value
(d) Train on Basel dataset and scale volumes of ADNI dataset to a reference value
It is however not possible with the available datasets to extrapolate our ﬁndings learned from
ADNI or Basel datasets to the Bonn dataset due to the presence of the co-linearity. This is an
important limitation of the present investigation. To perform such a task, a dataset that would
allow us to disentangle the CNR and voxel size is needed. Such a dataset should consist of a
series of measurements performed on several subjects where in each measurement the CNR
would be varied across a considerable range (in the context of present study from 2-7 a.u.) and
the voxel size would be varied independently.
The image-property-based leave-one-out validations performed well on each individual
dataset as illustrated in Figure 5.9, Figure 5.10, and Figure 5.11 and give hope regarding
the applicability of the presented approach. There were only very small differences between
protocol-based correction strategies and image-property-based correction strategies. When
CNR and voxel volume scaling factors were learned from the ADNI dataset and applied to
the Basel dataset similarly to the protocol-based correction strategy, we increased the sys-
tematic bias of GM and CSF volumes. However, this increase is smaller than with a purely
protocol-based compensation strategy. When the image-property-based model was trained
on the interpolated Basel dataset and the ADNI data was scaled to a reference value, the sys-
tematic biases were reduced. Note that for volumes of GM and CSF structures the bias is still
considerable and is higher than both scan-rescan variability and the results of leave-one-out
cross validation. This gives an indication that the image-property-based model may be overly
simplistic.
When leave-one-out cross validation of the image-property-based model is performed on
a combined dataset, systematic biases decrease dramatically. For volumes of GM and CSF
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structures this decrease was greater than the one of purely protocol-based correction strategy.
These ﬁndings indicate that one of the reasons for suboptimal performance in this scenario
when the model was trained on ADNI dataset and applied to Basel dataset may be insufﬁcient
size of the training database.
The applicability of both image-property-based and protocol-based models was studied using
a bootstrap procedure. The results from a leave-one-out cross validation on a combined
dataset can be susceptible to overﬁtting. Therefore, bootstrap procedure gives some further
insights into the applicability of our approach. In this context, it is illustrative to compare two
compensation strategies: a purely protocol-based and an image-property-based. Figure 5.15
and Figure 5.16 show that the image-property-based model was more generalizable. GM and
CSF structures illustrate this effect, and the best performance is achieved when the same age
range is used for both training and testing datasets. However, these plots also indicate that
the image-property-based compensation strategy is more robust when the range of ages is
different on training and testing datasets compared to protocol-based model.
Note that overall, while basic image parameters considered in the compensation strategies
investigated in the present thesis can help to mitigate some of the observed differences
between the protocols, further research into the metrics that can further parametrize the
image for automated volumetric assessment is needed. For instance, in the case of the
hippocampus volumes that can serve as a biomarker for Alzheimer’s disease, while there was
a signiﬁcant reduction in differences after applying compensation strategies to the sequential
volume measurements(reported RVDs need to be multiplied by a factor of 2 to be comparable
to results reported by [8]), the differences in volumes were still above the 3% that is necessary
to detect Alzheimer’s disease from the subject’s atrophy rate assessment.
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5.5 Conclusion
The analysis of sequential automated brain volume measurements performed on data ac-
quired with different protocols and systems discussed in the previous chapters indicated
possible discrepancies between brain volume measurements. The primary objective of this
study was to investigate the feasibility of compensation strategies.
The present study conﬁrmed previously reported ﬁndings on the feasibility of scaling morpho-
metric data to a reference value purely based on the protocols that were used. In both cases of
differences between 1.5T-3T ADNI protocols and between standard and accelerated protocols,
the resulting systematic bias can be greatly reduced with an application of appropriate scaling
coefﬁcients. However in contrast to the previous studies, the current study demonstrated
discrepancies in scaling coefﬁcients between young and old subjects or between different
hardware setups. Under these circumstances, caution must be exercised in application of
purely protocol-based compensation strategies as they may potentially conﬁne the atrophy
detection or the ability to detect differences between groups of subjects. This has very im-
portant consequences to a practical application of the protocol-based scaling procedures for
both clinical routine and research settings as it means that a separate calibration study would
need to be carried out for each new age group, protocol and system.
The results of this study give an indication that the image-property-based compensation
strategies can have the potential to be more robust compared to the protocol-based ones
when there are technology based variations in image content (SNR,CNR) across the subject
groups or hardware setups. In practical terms, this means that only one calibration study
would need to be performed and the subsequent data can be corrected even if new groups of
subjects that signiﬁcantly differ in contrast compared to the calibration group , acquisition
protocols or systems were to be introduced.
Overall, further research is needed to validate our ﬁndings. If we restrict ourselves to the
differences between 1.5T and 3T ADNI protocols, in the context of the current study an
independent test dataset is needed to further support the ﬁndings concerning the image-
property-based compensation strategy. This dataset must contain both young and old subjects
sampled uniformly across the age range. However, if we want to generalize to the accelerated
protocols, then both a separate training and testing datasets are needed. In such datasets,
for each subject, both the CNR and voxel volume has to be varied independently which will
allow to disentangle the CNR from voxel volume scaling coefﬁcients as well as scan-rescan
data needs to be available for each measurement.
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6 Conclusion and outlook
6.1 Conclusion
MRI is widely used for imaging both anatomy and physiological processes within the hu-
man brain. This thesis is focused on structural brain MRI, which can provide sufﬁcient
anatomical detail to perform quantitative volumetric measurements. Quantitative volumetric
measurements can serve as sensitive biomarkers to track atrophic brain regions, assess disease
progression, differentiate pathology from healthy aging, and monitor therapy response.
However, there is currently still a gap between state-of-the-art brain morphometry techniques
and everyday clinical practice. The main objective of this thesis was to understand the factors
that affect the adoption of automated quantitative volumetric brain measurements in clinical
practice and to examine possible compensation strategies to mitigate the effect of such factors.
The main obstacles that affect the adoption of the automated quantitative volumetric mea-
surements in clinical practice can be summarized as follows:
1. Sensitivity to variations in imaging protocol parameters:
Quantitative volumetric brain measurements from a particular subject need to be com-
parable over time. For instance, if atrophy rates are of interest, a bias in one of the time
points can potentially confound the assessment of the atrophy rate.
2. Availability of normative ranges:
One of the clinical use cases can be a comparison of the subject’s volume of a particular
brain structure to a database of age and sex-matched healthy controls with an aim to
get some insight into disease progression. However, this comparison can be challenging
if the data were acquired with a protocol that differs from the protocol used in the
construction of the normative range. It can be costly and not practical to construct a
normative database for every possible T1-weighted protocol. Moreover, if the patient
is not cooperative, it can be challenging to acquire the imaging data with the exact
parameters used in the construction of the normative range.
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Quantitative volumetric measurements can serve as a decision support tool for both clinicians
and researchers. Moving towards this goal and keeping in mind the hindrances that slow
down the adoption of quantitative volumetric measurements in clinical practice, the main
contributions of this thesis can be summarized as follows.
First, factors that can affect the automated volumetric measurements were examined.
In the context of Alzheimer’s and dementia, there has been a substantial effort to stan-
dardize the protocols across vendors and ﬁeld strength that led to the development of
the ADNI protocol. In this thesis, the reproducibility of ADNI protocol was examined
across different systems and contributions of technological (acquisition system, reposi-
tioning) and physiological (2 week gap between rescan) effects were investigated. Our
main result was that the compatibility of serial and cross-platform scans acquired with
the ADNI protocol can be best reached by minimizing differences in ﬁeld, protocol,
hardware, software, and physiology. We have observed signiﬁcant differences(biases)
in volumetric measurements between 1.5T and 3T protocols. With-in a ﬁeld strength,
an important ﬁnding is that most of the variability in the measurements was in back-
to-back differences and neither repositioning nor 2 week gap between a rescan did
signiﬁcantly increase the scan-rescan variability.
More generally, in the long-term perspective with the improvements in the MRI hard-
ware it is desirable to enable acquisition of data with the new advanced accelerated
protocols. The reduced acquisition time can reduce motion artifacts, improve patient
comfort, and increase the overall patient throughput. From a radiology department’s
management point of view, the most efﬁcient scanner usage is desirable to allow all
available scanners to contribute to serial exams rather than restricting the follow-up
exam to the previous scanner hardware. In the present thesis, four variants of a four-
fold-accelerated MPRAGE protocol (2D-GRAPPA, CAIPIRINHA, CAIPIRINHA elliptical,
and segmented MPRAGE) were examined and compared to the ADNI protocol with
respect to clinical readings, basic image quality metrics (SNR, CNR), and automated
brain tissue segmentation.
The main outcomes of this analysis were the following:
1. Brain scans with the four-fold-accelerated protocols provided very similar infor-
mation for qualitative readings in the 3T settings.
2. There were signiﬁcant differences in brain structure’s volume estimates between
conventional and highly accelerated protocols.
3. Our results suggest that volumetric biases (at least under the given study condi-
tions) were largely affected by the noise properties of the images.
Second, scaling procedures were examined as means for compensating for the observed
discrepancies in automated brain volume measurements between different systems or
protocols.
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6.1. Conclusion
The current state-of-the-art protocol-based and new proposed image-property-based
compensation strategies were examined and compared to each other. The results of this
work can be summarised as follows:
Current state-of-the-art protocol-based approaches can be used to correct for differ-
ences in automated brain volume measurements between systems and protocols. How-
ever, caution must be exercised when the results are extrapolated to a new group of
subjects that signiﬁcantly differ in CNR compared to the training dataset. Moreover,
whenever a new protocol, system or subject subgroup with signiﬁcantly different CNR
properties is introduced, a separate calibration study needs to be carried out to learn
the scaling coefﬁcients for this particular protocol, system or subject subgroup.
The new proposed image-property-based correction strategy can be applied to cor-
rect for differences in automated brain volume estimates using heterogeneous systems
and/or protocols, without knowledge of the said systems or protocols. There can be
signiﬁcant beneﬁts from applying image-property-based correction strategies as op-
posed to protocol-based approaches since they are potentially more generalizable to
unseen systems and protocols. In practical terms, this means that only one calibration
study needs to be performed and the subsequent data can be corrected even if a new
acquisition protocol, system, or group of subjects with substantially different CNR were
to be introduced later into the study.
In summary, this thesis identiﬁed the factors that can affect the reproducibility of the sequen-
tial automated brain tissue segmentations and investigated the applicability of compensation
strategies to facilitate adoption of automated quantitative volumetric measurements in clinical
practice.
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6.2 Future Research
Further research is needed to validate the image-property-based approach of scaling volu-
metric data to a ﬁxed reference. The validation of the image-property-based approach can be
divided into two parts:
1. Differences between 1.5T and 3T ADNI protocols: In the context of the present thesis,
an independent testing dataset is needed to further support our ﬁndings. This dataset
must contain both young and old subjects sampled uniformly across the age range.
2. Accelerated protocols: In addition to the data collected during the present thesis, sepa-
rate training and testing datasets are needed. In such datasets, for each subject, both
the CNR and voxel volume would need to be varied independently. This would allow to
better disentangle the CNR from voxel volume scaling coefﬁcients than using protocols
in which CNR and voxel size were roughly matched.
Overall, the image-property-based model considered that CNR and voxel volume can explain
the differences between consecutive acquisitions. However, this model may be over simplistic
and additional image quality metrics could be considered.
In the present thesis, we aimed to gain some understanding of the effects that acquisition
parameters of T1-weighted structural brain imaging have on automated brain volume seg-
mentation and volumetric biomarker extraction. Further research is needed to reﬁne the
correction strategies proposed in this thesis as well as to determine the effect of protocol
parameters on other automated post processing algorithms. An example of this is automated
lesion segmentation in the context of multiple sclerosis, where lesion volumes and total le-
sion load are biomarkers of interest, which are likely to be system and protocol-dependent.
Protocol-based or image-property based approaches could be considered if discrepancies in
the lesion volume measurements are observed between different protocols or systems.
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A.1 Reproducibility of volumetric data acquired with a standard-
ized T1-weighted brain-imaging protocol
%TIV
Between Subjects Std. 1.2585
Scan - Rescan Std. 0.8960
Std. due to R2 0.2106
Std. due to R3 0.2068
ESPREE - AVANTO -0.7854 ***
SKYRA - AVANTO -1.0864 ***
PRISMA - AVANTO -1.0268 ***
Age(years) 0.0852
SEX(MALE) 2.6138 ***
(a) WM
%TIV
Between Subjects Std. 0.9101
Scan - Rescan Std. 0.8432
Std. due to R2 0.3386
Std. due to R3 0.4414
ESPREE - AVANTO 0.7087 ***
SKYRA - AVANTO 1.1430 ***
PRISMA - AVANTO 0.7417 ***
Age(years) -0.1247 *
SEX(MALE) -2.3068 ***
(b) GM
%TIV
Between Subjects Std. 1.4844
Scan - Rescan Std. 0.6421
Std. due to R2 0.1959
Std. due to R3 0.2824
ESPREE - AVANTO 0.0767
SKYRA - AVANTO -0.0561
PRISMA - AVANTO 0.2853 **
Age(years) 0.0155
SEX(MALE) -0.0451
(c) CSF
%TIV
Between Subjects Std. 1.4840
Scan - Rescan Std. 0.6425
Std. due to R2 0.1962
Std. due to R3 0.2822
ESPREE - AVANTO -0.0770
SKYRA - AVANTO 0.0566
PRISMA - AVANTO -0.2857 **
Age(years) -0.0154
SEX(MALE) 0.0454
(d) NBV
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%TIV
Between Subjects Std. 0.0331
Scan - Rescan Std. 0.0137
Std. due to R2 0.0054
Std. due to R3 0.0033
ESPREE - AVANTO -0.0011
SKYRA - AVANTO 0.0136 ***
PRISMA - AVANTO 0.0148 ***
Age(years) -0.0005
SEX(MALE) -0.0093
(a) Hippocampus
%TIV
Between Subjects Std. 0.0745
Scan - Rescan Std. 0.0238
Std. due to R2 0.0045
Std. due to R3 0.0052
ESPREE - AVANTO 0.0101 *
SKYRA - AVANTO 0.0608 ***
PRISMA - AVANTO 0.0630 ***
Age(years) -0.0058
SEX(MALE) 0.0055
(b) Thalamus
%TIV
Between Subjects Std. 0.0407
Scan - Rescan Std. 0.0218
Std. due to R2 0.0043
Std. due to R3 0.0082
ESPREE - AVANTO 0.0018
SKYRA - AVANTO -0.0206 ***
PRISMA - AVANTO -0.0143 ***
Age(years) 0.0028
SEX(MALE) -0.0272
(c) Putamen
%TIV
Between Subjects Std. 0.0455
Scan - Rescan Std. 0.0140
Std. due to R2 0.0001
Std. due to R3 0.0016
ESPREE - AVANTO 0.0018
SKYRA - AVANTO 0.0141 ***
PRISMA - AVANTO 0.0236 ***
Age(years) -0.0002
SEX(MALE) -0.0409 *
(d) Caudate
%TIV
Between Subjects Std. 0.0118
Scan - Rescan Std. 0.0107
Std. due to R2 0.0004
Std. due to R3 0.0021
ESPREE - AVANTO 0.0010
SKYRA - AVANTO 0.0125 ***
PRISMA - AVANTO 0.0154 ***
Age(years) 0.0010
SEX(MALE) 0.0009
(e) Pallidum
Table A.1: Regression coefﬁcients as ﬁt by the linear mixed-effect model. * p<0.05; ** p<10-2;
*** p<10-3
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brain-imaging protocol
%TIV
ESPREE - AVANTO -0.7854 ***
PRISMA - AVANTO -1.0268 ***
SKYRA - AVANTO -1.0864 ***
PRISMA - ESPREE -0.2414
SKYRA - ESPREE -0.3010
SKYRA - PRISMA -0.0595
(a) WM
%TIV
ESPREE - AVANTO 0.7087 ***
PRISMA - AVANTO 0.7417 ***
SKYRA - AVANTO 1.1430 ***
PRISMA - ESPREE 0.0330
SKYRA - ESPREE 0.4343
SKYRA - PRISMA 0.4013
(b) GM
%TIV
ESPREE - AVANTO 0.0767
PRISMA - AVANTO 0.2853 *
SKYRA - AVANTO -0.0561
PRISMA - ESPREE 0.2086
SKYRA - ESPREE -0.1328
SKYRA - PRISMA -0.3414 *
(c) CSF
%TIV
ESPREE - AVANTO -0.0770
PRISMA - AVANTO -0.2857 *
SKYRA - AVANTO 0.0566
PRISMA - ESPREE -0.2087
SKYRA - ESPREE 0.1336
SKYRA - PRISMA 0.3423 *
(d) NBV
%TIV
ESPREE - AVANTO -0.0011
PRISMA - AVANTO 0.0148 ***
SKYRA - AVANTO 0.0136 ***
PRISMA - ESPREE 0.0159 ***
SKYRA - ESPREE 0.0147 ***
SKYRA - PRISMA -0.0013
(e) Hippocampus
%TIV
ESPREE - AVANTO 0.0101
PRISMA - AVANTO 0.0630 ***
SKYRA - AVANTO 0.0608 ***
PRISMA - ESPREE 0.0529 ***
SKYRA - ESPREE 0.0508 ***
SKYRA - PRISMA -0.0022
(f) Thalamus
%TIV
ESPREE - AVANTO 0.0018
PRISMA - AVANTO -0.0143 ***
SKYRA - AVANTO -0.0206 ***
PRISMA - ESPREE -0.0161 ***
SKYRA - ESPREE -0.0224 ***
SKYRA - PRISMA -0.0063
(g) Putamen
%TIV
ESPREE - AVANTO 0.0018
PRISMA - AVANTO 0.0236 ***
SKYRA - AVANTO 0.0141 ***
PRISMA - ESPREE 0.0217 ***
SKYRA - ESPREE 0.0123 ***
SKYRA - PRISMA -0.0094 **
(h) Caudate
%TIV
ESPREE - AVANTO 0.0010
PRISMA - AVANTO 0.0154 ***
SKYRA - AVANTO 0.0125 ***
PRISMA - ESPREE 0.0144 ***
SKYRA - ESPREE 0.0115 ***
SKYRA - PRISMA -0.0029
(i) Pallidum
Table A.2: Volume differences for all possible scanner combinations. * p<0.05; ** p<10-2; ***
p<10-3
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A.2 Correction and optimization strategies towards reliable and ro-
bust estimation of data elements
A.2.1 Protocol-based compensation strategy
Adjusted Mean RVD Original Mean RVD Target Mean RVD
WM 0.0136 0.0296 0.0062
GM 0.0144 0.0398 0.0058
CSF 0.0146 0.0272 0.0094
NBV 0.0066 0.0115 0.0036
Hippocampus 0.0183 0.0424 0.0113
Thalamus 0.0149 0.0293 0.0082
Putamen 0.0150 0.0156 0.0087
Caudate 0.0197 0.0347 0.0117
Pallidum 0.0241 0.0255 0.0171
Table A.3: Mean relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T (Target,
pure scan-rescan variability) of ADNI dataset with protocol-based compensation strategy
computed in leave-one-out cross-validation settings
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A.2. Correction and optimization strategies towards reliable and robust estimation of
data elements
Adjusted Mean RVD Original Mean RVD Target Mean RVD
WM 0.0137 0.0212 0.0120
GM 0.0094 0.0124 0.0089
CSF 0.0220 0.0224 0.0195
NBV 0.0050 0.0051 0.0045
Hippocampus 0.0193 0.0234 0.0184
Thalamus 0.0140 0.0361 0.0132
Putamen 0.0133 0.0132 0.0116
Caudate 0.0124 0.0241 0.0126
Pallidum 0.0235 0.0304 0.0235
Table A.4: Mean relative volume differences 1.5T/3T (Adjusted, Original) and 3T/3T (Target,
pure scan-rescan variability) of interpolated Basel dataset with protocol-based compensation
strategy computed in leave-one-out cross-validation settings
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Adjusted Mean RVD Original Mean RVD
WM 0.0053 0.0266
GM 0.0081 0.0122
CSF 0.0198 0.0244
NBV 0.0045 0.0055
Hippocampus 0.0127 0.0120
Thalamus 0.0070 0.0090
Putamen 0.0100 0.0096
Caudate 0.0084 0.0117
Pallidum 0.0168 0.0183
(a) ADNI2-2D-GRAPPA
Adjusted Mean RVD Original Mean RVD
WM 0.0052 0.0170
GM 0.0073 0.0076
CSF 0.0169 0.0204
NBV 0.0039 0.0047
Hippocampus 0.0149 0.0144
Thalamus 0.0075 0.0071
Putamen 0.0075 0.0075
Caudate 0.0063 0.0066
Pallidum 0.0127 0.0118
(b) ADNI2-CAIPI
Adjusted Mean RVD Original Mean RVD
WM 0.0038 0.0152
GM 0.0092 0.0087
CSF 0.0212 0.0236
NBV 0.0048 0.0053
Hippocampus 0.0099 0.0115
Thalamus 0.0080 0.0076
Putamen 0.0078 0.0076
Caudate 0.0074 0.0078
Pallidum 0.0174 0.0163
(c) ADNI2-CAIPI el
Adjusted Mean RVD Original Mean RVD
WM 0.0085 0.0266
GM 0.0113 0.0111
CSF 0.0229 0.0467
NBV 0.0053 0.0103
Hippocampus 0.0165 0.0156
Thalamus 0.0094 0.0102
Putamen 0.0108 0.0103
Caudate 0.0084 0.0083
Pallidum 0.0158 0.0155
(d) ADNI2-Seg.MPRAGE
Table A.5: Mean relative volume differences ADNI-2/accerated protocols (Original, Adjusted)
of Bonn dataset with protocol-based compensation strategy computed in leave-one-out cross-
validation settings
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A.2. Correction and optimization strategies towards reliable and robust estimation of
data elements
Adjusted Mean RVD Original Mean RVD Target Mean RVD
WM 0.0170 0.0212 0.0120
GM 0.0317 0.0124 0.0089
CSF 0.0379 0.0224 0.0195
NBV 0.0131 0.0051 0.0045
Hippocampus 0.0296 0.0234 0.0184
Thalamus 0.0137 0.0361 0.0132
Putamen 0.0140 0.0132 0.0116
Caudate 0.0160 0.0241 0.0126
Pallidum 0.0242 0.0304 0.0235
Table A.6: Mean relative volume differences 1.5T/3T (Original, Adjusted) and 3T/3T (Target
pure scan-rescan variability) of interpolated Basel dataset with protocol-based compensa-
tion strategy computed when the model is trained on ADNI dataset and applied to scale
interpolated Basel dataset
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Adjusted Mean RVD Original Mean RVD Target Mean RVD
WM 0.0151 0.0296 0.0062
GM 0.0305 0.0398 0.0058
CSF 0.0342 0.0272 0.0094
NBV 0.0130 0.0115 0.0036
Hippocampus 0.0293 0.0424 0.0113
Thalamus 0.0164 0.0293 0.0082
Putamen 0.0153 0.0156 0.0087
Caudate 0.0199 0.0347 0.0117
Pallidum 0.0257 0.0255 0.0171
Table A.7: Mean relative volume differences 1.5T/3T (original/corrected) and 3T/3T (Target,
pure scan-rescan variability) of ADNI dataset with protocol-based compensation strategy
computed when the model is trained on interpolated Basel dataset and applied to scale ADNI
dataset
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A.2. Correction and optimization strategies towards reliable and robust estimation of
data elements
Adjusted Mean RVD Original Mean RVD Target Mean RVD
WM 0.0139 0.0296 0.0062
GM 0.0188 0.0398 0.0058
CSF 0.0218 0.0272 0.0094
NBV 0.0087 0.0115 0.0036
Hippocampus 0.0216 0.0424 0.0113
Thalamus 0.0154 0.0293 0.0082
Putamen 0.0150 0.0156 0.0087
Caudate 0.0193 0.0347 0.0117
Pallidum 0.0247 0.0255 0.0171
Table A.8: Mean relative volume differences of ADNI dataset 1.5T/3T (Adjusted, Original)
and 3T/3T (Target, pure scan-rescan variability). Combined dataset with protocol-based
compensation strategy computed in leave-one-out cross-validation settings.
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Adjusted Mean RVD Original Mean RVD Target Mean RVD
WM 0.0148 0.0212 0.0120
GM 0.0164 0.0124 0.0089
CSF 0.0256 0.0224 0.0195
NBV 0.0071 0.0051 0.0045
Hippocampus 0.0209 0.0234 0.0184
Thalamus 0.0135 0.0361 0.0132
Putamen 0.0134 0.0132 0.0116
Caudate 0.0132 0.0241 0.0126
Pallidum 0.0236 0.0304 0.0235
Table A.9: Mean relative volume differences of interpolated Basel dataset 1.5T/3T (Adjusted,
Original) and 3T/3T (Target, pure scan-rescan variability). Combined dataset with protocol-
based compensation strategy computed in leave-one-out cross-validation settings.
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data elements
A.2.2 Image-property-based compensation strategy
Adjusted Mean RVD Original Mean RVD
WM 0.0128 0.0296
GM 0.0113 0.0398
CSF 0.0139 0.0272
NBV 0.0061 0.0115
Hippocampus 0.0189 0.0424
Thalamus 0.0153 0.0293
Putamen 0.0157 0.0156
Caudate 0.0183 0.0347
Pallidum 0.0237 0.0255
(a) 3T-1.5T
Adjusted Mean RVD Original Mean RVD
WM 0.0065 0.0062
GM 0.0055 0.0058
CSF 0.0089 0.0094
NBV 0.0033 0.0036
Hippocampus 0.0112 0.0113
Thalamus 0.0080 0.0082
Putamen 0.0092 0.0087
Caudate 0.0115 0.0117
Pallidum 0.0181 0.0171
(b) 3T-3T
Table A.10: Mean relative volume differences (Adjusted, Original) 1.5T/3T and 3T/3T of ADNI
dataset with image-property-based compensation strategy computed in leave-one-out cross-
validation settings
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Adjusted Mean RVD Original Mean RVD
WM 0.0146 0.0212
GM 0.0093 0.0124
CSF 0.0189 0.0224
NBV 0.0043 0.0051
Hippocampus 0.0200 0.0234
Thalamus 0.0140 0.0361
Putamen 0.0134 0.0132
Caudate 0.0131 0.0241
Pallidum 0.0243 0.0304
(a) 3T-1.5T
Adjusted Mean RVD Original Mean RVD
WM 0.0111 0.0120
GM 0.0085 0.0089
CSF 0.0165 0.0195
NBV 0.0037 0.0045
Hippocampus 0.0189 0.0184
Thalamus 0.0131 0.0132
Putamen 0.0119 0.0116
Caudate 0.0134 0.0126
Pallidum 0.0236 0.0235
(b) 3T-3T
Table A.11: Mean relative volume differences (Adjusted, Original) 1.5T/3T and 3T/3T of in-
terpolated Basel dataset with image-property-based compensation strategy computed in
leave-one-out cross-validation settings
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data elements
Adjusted Mean RVD Original Mean RVD
WM 0.0166 0.0266
GM 0.0121 0.0122
CSF 0.0179 0.0244
NBV 0.0037 0.0055
Hippocampus 0.0126 0.0120
Thalamus 0.0091 0.0090
Putamen 0.0099 0.0096
Caudate 0.0101 0.0117
Pallidum 0.0185 0.0183
(a) ADNI2-2D-GRAPPA
Adjusted Mean RVD Original Mean RVD
WM 0.0137 0.0170
GM 0.0065 0.0076
CSF 0.0175 0.0204
NBV 0.0036 0.0047
Hippocampus 0.0140 0.0144
Thalamus 0.0073 0.0071
Putamen 0.0072 0.0075
Caudate 0.0063 0.0066
Pallidum 0.0124 0.0118
(b) ADNI2-CAIPI
Adjusted Mean RVD Original Mean RVD
WM 0.0119 0.0152
GM 0.0073 0.0087
CSF 0.0184 0.0236
NBV 0.0039 0.0053
Hippocampus 0.0113 0.0115
Thalamus 0.0078 0.0076
Putamen 0.0075 0.0076
Caudate 0.0084 0.0078
Pallidum 0.0176 0.0163
(c) ADNI2-CAIPI el
Adjusted Mean RVD Original Mean RVD
WM 0.0211 0.0266
GM 0.0094 0.0111
CSF 0.0324 0.0467
NBV 0.0068 0.0103
Hippocampus 0.0155 0.0156
Thalamus 0.0105 0.0102
Putamen 0.0102 0.0103
Caudate 0.0086 0.0083
Pallidum 0.0161 0.0155
(d) ADNI2-Seg.MPRAGE
Table A.12: Mean relative volume differences ADNI-2/accerated protocols (Original, Adjusted)
of Bonn dataset with image-property-based compensation strategy computed in leave-one-
out cross-validation settings
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Adjusted Mean RVD Original Mean RVD
WM 0.0130 0.0212
GM 0.0169 0.0124
CSF 0.0318 0.0224
NBV 0.0084 0.0051
Hippocampus 0.0251 0.0234
Thalamus 0.0135 0.0361
Putamen 0.0160 0.0132
Caudate 0.0159 0.0241
Pallidum 0.0234 0.0304
(a) 3T-1.5T
Adjusted Mean RVD Original Mean RVD
WM 0.0110 0.0120
GM 0.0082 0.0089
CSF 0.0190 0.0195
NBV 0.0042 0.0045
Hippocampus 0.0186 0.0184
Thalamus 0.0131 0.0132
Putamen 0.0117 0.0116
Caudate 0.0142 0.0126
Pallidum 0.0233 0.0235
(b) 3T-3T
Table A.13: Mean relative volume differences (Adjusted, Original) between 1.5T/3T and 3T/3T
of interpolated Basel dataset with image-property-based compensation strategy trained on
ADNI dataset
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data elements
Adjusted Mean RVD Original Mean RVD
WM 0.0217 0.0296
GM 0.0147 0.0398
CSF 0.0440 0.0272
NBV 0.0083 0.0115
Hippocampus 0.0311 0.0424
Thalamus 0.0188 0.0293
Putamen 0.0175 0.0156
Caudate 0.0204 0.0347
Pallidum 0.0252 0.0255
(a) 3T-1.5T
Adjusted Mean RVD Original Mean RVD
WM 0.0111 0.0062
GM 0.0055 0.0058
CSF 0.0206 0.0094
NBV 0.0052 0.0036
Hippocampus 0.0114 0.0113
Thalamus 0.0093 0.0082
Putamen 0.0095 0.0087
Caudate 0.0117 0.0117
Pallidum 0.0188 0.0171
(b) 3T-3T
Table A.14: Mean relative volume differences (Adjusted, Original) between 1.5T/3T and 3T/3T
of ADNI dataset with image-property-based compensation strategy trained on interpolated
Basel dataset
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Adjusted Mean RVD Original Mean RVD
WM 0.0127 0.0296
GM 0.0106 0.0398
CSF 0.0149 0.0272
NBV 0.0060 0.0115
Hippocampus 0.0191 0.0424
Thalamus 0.0160 0.0293
Putamen 0.0155 0.0156
Caudate 0.0183 0.0347
Pallidum 0.0236 0.0255
(a) 3T-1.5T
Adjusted Mean RVD Original Mean RVD
WM 0.0066 0.0062
GM 0.0053 0.0058
CSF 0.0091 0.0094
NBV 0.0034 0.0036
Hippocampus 0.0111 0.0113
Thalamus 0.0082 0.0082
Putamen 0.0091 0.0087
Caudate 0.0115 0.0117
Pallidum 0.0181 0.0171
(b) 3T-3T
Table A.15: Mean relative volume differences of interpolated Basel dataset (Adjusted, Original)
between 1.5T/3T and 3T/3T. Combined dataset with image-property-based compensation
strategy computed in leave-one-out cross-validation settings.
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A.2. Correction and optimization strategies towards reliable and robust estimation of
data elements
Adjusted Mean RVD Original Mean RVD
WM 0.0134 0.0212
GM 0.0101 0.0124
CSF 0.0216 0.0224
NBV 0.0049 0.0051
Hippocampus 0.0195 0.0234
Thalamus 0.0132 0.0361
Putamen 0.0132 0.0132
Caudate 0.0129 0.0241
Pallidum 0.0236 0.0304
(a) 3T-1.5T
Adjusted Mean RVD Original Mean RVD
WM 0.0109 0.0120
GM 0.0083 0.0089
CSF 0.0183 0.0195
NBV 0.0040 0.0045
Hippocampus 0.0190 0.0184
Thalamus 0.0130 0.0132
Putamen 0.0118 0.0116
Caudate 0.0135 0.0126
Pallidum 0.0234 0.0235
(b) 3T-3T
Table A.16: Mean relative volume differences of ADNI dataset (Adjusted, Original) between
1.5T/3T and 3T/3T. Combined dataset with image property based compensation strategy
computed in leave-one-out cross-validation settings.
93

Bibliography
[1] J. C. Baron, G. Chételat, B. Desgranges, G. Perchey, B. Landeau, V. de la Sayette, and
F. Eustache, “In vivo mapping of gray matter loss with voxel-based morphometry in mild
Alzheimer’s disease.,” NeuroImage, vol. 14, no. 2, pp. 298–309, 2001.
[2] N. Bernasconi, S. Duchesne, A. Janke, J. Lerch, D. L. Collins, and A. Bernasconi, “Whole-
brain voxel-based statistical analysis of gray matter and white matter in temporal lobe
epilepsy,” NeuroImage, vol. 23, no. 2, pp. 717–723, 2004.
[3] L. Bonilha, C. Rorden, J. J. Halford, M. Eckert, S. Appenzeller, F. Cendes, and L. M. Li,
“Asymmetrical extra-hippocampal grey matter loss related to hippocampal atrophy in
patients with medial temporal lobe epilepsy,” Journal of Neurology, Neurosurgery &
Psychiatry, vol. 78, no. 3, pp. 286–294, 2006.
[4] E. J. Burton, I. G. McKeith, D. J. Burn, E. D. Williams, and J. T. O’Brien, “Cerebral atrophy in
Parkinson’s disease with and without dementia: A comparison with Alzheimer’s disease,
dementia with Lewy bodies and controls,” Brain, vol. 127, no. 4, pp. 791–800, 2004.
[5] R. Camicioli, M. Gee, T. P. Bouchard, N. J. Fisher, C. C. Hanstock, D. J. Emery, and W. R. W.
Martin, “Voxel-based morphometry reveals extra-nigral atrophy patterns associated with
dopamine refractory cognitive and motor impairment in parkinsonism,” Parkinsonism &
related disorders, vol. 15, pp. 187–95, mar 2009.
[6] G. Chételat, B. Landeau, F. Eustache, F. Mézenge, F. Viader, V. De La Sayette, B. Desgranges,
and J. C. Baron, “Using voxel-based morphometry to map the structural changes associ-
ated with rapid conversion in MCI: A longitudinal MRI study,” NeuroImage, vol. 27, no. 4,
pp. 934–946, 2005.
[7] A. Cifelli, M. Arridge, P. Jezzard, M. M. Esiri, J. Palace, and P. M. Matthews, “Thalamic
neurodegeneration in multiple sclerosis,” Annals of Neurology, vol. 52, no. 5, pp. 650–653,
2002.
[8] G. B. Frisoni, N. C. Fox, C. R. Jack, P. Scheltens, and P. M. Thompson, “The clinical use of
structural MRI in Alzheimer disease,” Nat Rev Neurol, vol. 6, pp. 67–77, feb 2010.
[9] C. R. Jack, V. J. Lowe, S. D. Weigand, H. J. Wiste, M. L. Senjem, D. S. Knopman, M. M.
Shiung, J. L. Gunter, B. F. Boeve, B. J. Kemp, M. Weiner, and R. C. Petersen, “Serial PIB
95
Bibliography
and MRI in normal, mild cognitive impairment and Alzheimers disease: Implications for
sequence of pathological events in Alzheimers disease,” Brain, vol. 132, no. 5, pp. 1355–
1365, 2009.
[10] R. Kikinis, C. R. Guttmann, D. Metcalf, W. M. Wells, G. J. Ettinger, H. L. Weiner, and F. A.
Jolesz, “Quantitative follow-up of patients with multiple sclerosis using MRI: technical
aspects.,” Journal of Magnetic Resonance Imaging, vol. 9, no. 4, pp. 519–30, 1999.
[11] M. P. Sanﬁlipo, R. H. B. Benedict, B. Weinstock-Guttman, and R. Bakshi, “Gray and
white matter brain atrophy and neuropsychological impairment in multiple sclerosis,”
Neurology, vol. 66, pp. 685–692, mar 2006.
[12] D. Schmitter, A. Roche, B. Maréchal, D. Ribes, A. Abdulkadir, M. Bach-Cuadra, A. Da-
ducci, C. Granziera, S. Klöppel, P. Maeder, R. Meuli, and G. Krueger, “An evaluation of
volume-based morphometry for prediction ofmild cognitive impairment and Alzheimer’s
disease,” NeuroImage. Clinical, vol. 7, pp. 7–17, jan 2015.
[13] G. Tao, S. Datta, R. He, F. Nelson, J. S. Wolinsky, and P. A. Narayana, “Deep Gray Matter
Atrophy in Multiple Sclerosis: A Tensor Based Morphometry,” jul 2009.
[14] J. L. Whitwell, S. D. Weigand, M. M. Shiung, B. F. Boeve, T. J. Ferman, G. E. Smith, D. S.
Knopman, R. C. Petersen, E. E. Benarroch, K. A. Josephs, and C. R. Jack, “Focal atrophy in
Dementia with Lewy Bodies on MRI: a distinct pattern from Alzheimer’s disease,” mar
2007.
[15] I. C. Wright, Z. R. Ellison, T. Sharma, K. J. Friston, R. M. Murray, and P. K. McGuire,
“Mapping of grey matter changes in schizophrenia,” Schizophrenia Research, vol. 35, no. 1,
pp. 1–14, 1999.
[16] C. R. Jack, M. A. Bernstein, N. C. Fox, P. Thompson, G. Alexander, D. Harvey, B. Borowski,
P. J. Britson, J. L. Whitwell, C. Ward, A. M. Dale, J. P. Felmlee, J. L. Gunter, D. L. Hill,
R. Killiany, N. Schuff, S. Fox-Bosetti, C. Lin, C. Studholme, C. S. DeCarli, G. Krueger, H. A.
Ward, G. J. Metzger, K. T. Scott, R. Mallozzi, D. Blezek, J. Levy, J. P. Debbins, A. S. Fleisher,
M. Albert, R. Green, G. Bartzokis, G. Glover, J. Mugler, and M. W. Weiner, “The Alzheimer’s
Disease Neuroimaging Initiative (ADNI): MRI methods,” Journal of magnetic resonance
imaging : JMRI, vol. 27, pp. 685–91, apr 2008.
[17] C. R. Jack, M. A. Bernstein, B. J. Borowski, J. L. Gunter, N. C. Fox, P. M. Thompson,
N. Schuff, G. Krueger, R. J. Killiany, C. S. Decarli, A. M. Dale, O. W. Carmichael, D. Tosun,
and M. W. Weiner, “Update on the magnetic resonance imaging core of the Alzheimer’s
disease neuroimaging initiative,” Alzheimer’s & dementia : the journal of the Alzheimer’s
Association, vol. 6, pp. 212–20, may 2010.
[18] C. R. K. Ching, X. Hua, D. P. Hibar, C. P. Ward, J. L. Gunter, M. A. Bernstein, C. R. Jack, M. W.
Weiner, and P. M. Thompson, “Does MRI scan acceleration affect power to track brain
change?,” Neurobiology of aging, vol. 36 Suppl 1, pp. S167–77, jan 2015.
96
Bibliography
[19] J. Jovicich, S. Czanner, D. Greve, E. Haley, A. van der Kouwe, R. Gollub, D. Kennedy,
F. Schmitt, G. Brown, J. Macfall, B. Fischl, and A. Dale, “Reliability in multi-site structural
MRI studies: effects of gradient non-linearity correction on phantom and human data,”
NeuroImage, vol. 30, pp. 436–43, apr 2006.
[20] J. Jovicich, S. Czanner, X. Han, D. Salat, A. van der Kouwe, B. Quinn, J. Pacheco, M. Albert,
R. Killiany, D. Blacker, P. Maguire, D. Rosas, N. Makris, R. Gollub, A. Dale, B. C. Dickerson,
and B. Fischl, “MRI-derived measurements of human subcortical, ventricular and in-
tracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data
analyses, scanner upgrade, scanner vendors and ﬁeld strengths,” NeuroImage, vol. 46,
pp. 177–92, may 2009.
[21] J. Jovicich, M. Marizzoni, R. Sala-Llonch, B. Bosch, D. Bartrés-Faz, J. Arnold, J. Ben-
ninghoff, J. Wiltfang, L. Roccatagliata, F. Nobili, T. Hensch, A. Tränkner, P. Schönknecht,
M. Leroy, R. Lopes, R. Bordet, V. Chanoine, J.-P. Ranjeva, M. Didic, H. Gros-Dagnac, P. Pay-
oux, G. Zoccatelli, F. Alessandrini, A. Beltramello, N. Bargalló, O. Blin, and G. B. Frisoni,
“Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of
cross-sectional and longitudinal segmentations,” NeuroImage, vol. 83, pp. 472–84, dec
2013.
[22] G. Krueger, C. Granziera, C. R. Jack, J. L. Gunter, A. Littmann, B. Mortamet, S. Kan-
nengiesser, A. G. Sorensen, C. P. Ward, D. A. Reyes, P. J. Britson, H. Fischer, and M. A.
Bernstein, “Effects of MRI scan acceleration on brain volume measurement consistency,”
Journal of magnetic resonance imaging : JMRI, vol. 36, pp. 1234–40, nov 2012.
[23] F. Kruggel, J. Turner, and L. T.Muftuler, “Impact of scanner hardware and imaging protocol
on image quality and compartment volume precision in the ADNI cohort,” NeuroImage,
vol. 49, pp. 2123–33, feb 2010.
[24] K. K. Leung, I. M. Malone, S. Ourselin, J. L. Gunter, M. a. Bernstein, P. M. Thompson,
C. R. Jack, M. W. Weiner, and N. C. Fox, “Effects of changing from non-accelerated to
accelerated MRI for follow-up in brain atrophy measurement,” NeuroImage, vol. 107C,
pp. 46–53, dec 2014.
[25] R. A. Morey, E. S. Selgrade, H. R. Wagner, S. A. Huettel, L. Wang, and G. McCarthy, “Scan-
rescan reliability of subcortical brain volumes derived from automated segmentation,”
Human brain mapping, vol. 31, pp. 1751–62, nov 2010.
[26] M. Reuter, N. J. Schmansky, H. D. Rosas, and B. Fischl, “Within-subject template esti-
mation for unbiased longitudinal image analysis,” NeuroImage, vol. 61, pp. 1402–18, jul
2012.
[27] J. S. Wonderlick, D. A. Ziegler, P. Hosseini-Varnamkhasti, J. J. Locascio, A. Bakkour,
A. van der Kouwe, C. Triantafyllou, S. Corkin, and B. C. Dickerson, “Reliability of MRI-
derived cortical and subcortical morphometric measures: effects of pulse sequence, voxel
geometry, and parallel imaging,” NeuroImage, vol. 44, pp. 1324–33, feb 2009.
97
Bibliography
[28] J. P. Mugler and J. R. Brookeman, “Three-dimensional magnetization-prepared rapid
gradient-echo imaging (3D MP RAGE),” Magnetic Resonance in Medicine, vol. 15, no. 1,
pp. 152–157, 1990.
[29] M. A. Griswold, P. M. Jakob, R. M. Heidemann, M. Nittka, V. Jellus, J. Wang, B. Kiefer,
and A. Haase, “Generalized autocalibrating partially parallel acquisitions (GRAPPA),”
Magnetic resonance in medicine : ofﬁcial journal of the Society of Magnetic Resonance in
Medicine / Society of Magnetic Resonance in Medicine, vol. 47, pp. 1202–10, jun 2002.
[30] K. P. Pruessmann, M. Weiger, M. B. Scheidegger, and P. Boesiger, “SENSE: Sensitivity
encoding for fast MRI,” Magnetic Resonance in Medicine, vol. 42, no. 5, pp. 952–962, 1999.
[31] C. Studholme, D. L. G. Hill, and D. J. Hawkes, “An overlap invariant entropy measure of
3D medical image alignment,” Pattern Recognition, vol. 32, pp. 71–86, 1999.
[32] C. Chefd’hotel, G. Hermosillo, and O. Faugeras, “Flows of diffeomorphisms for multi-
modal image registration,” in Biomedical Imaging, 2002. Proceedings. 2002 IEEE Interna-
tional Symposium on, pp. 753–756, 2002.
[33] J. Ashburner and K. J. Friston, “Uniﬁed segmentation,” NeuroImage, vol. 26, no. 3, pp. 839–
851, 2005.
[34] M. B. Cuadra, L. Cammoun, T. Butz, O. Cuisenaire, and J. P. Thiran, “Comparison and
validation of tissue modelization and statistical classiﬁcation methods in T1-weighted
MR brain images,” IEEE Transactions on Medical Imaging, vol. 24, no. 12, pp. 1548–1565,
2005.
[35] K. Van Leemput, F. Maes, D. Vandermeulen, and P. Suetens, “Automated model-based
tissue classiﬁcation of MR images of the brain.,” IEEE transactions on medical imaging,
vol. 18, no. 10, pp. 897–908, 1999.
[36] M. Albert, S. DeKosky, D. Dickson, B. Dubois, H. Feldman, N. Fox, a. Gamst, D. Holtzman,
W. Jagust, R. C. Petersen, P. Snyder, M. Carrillo, B. Theis, and C. Phelps, “The diagnosis
of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the
National Institute on Aging-Alzheimer’s Association workgroups on,” Alzheimer’s & . . . ,
vol. 7, no. 3, pp. 270–279, 2011.
[37] G. M. McKhann, D. S. Knopman, H. Chertkow, B. T. Hyman, C. R. Jack, C. H. Kawas, W. E.
Klunk, W. J. Koroshetz, J. J. Manly, R. Mayeux, R. C. Mohs, J. C. Morris, M. N. Rossor,
P. Scheltens, M. C. Carrillo, B. Thies, S. Weintraub, and C. H. Phelps, “The diagnosis of
dementia due to Alzheimer’s disease: Recommendations from the National Institute
on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s
disease,” Alzheimer’s & Dementia, vol. 7, no. 3, pp. 263–269, 2011.
[38] D. O. Walsh, A. F. Gmitro, and M. W. Marcellin, “Adaptive reconstruction of phased array
MR imagery,” Magnetic Resonance in Medicine, vol. 43, no. 5, pp. 682–690, 2000.
98
Bibliography
[39] A. Roche, D. Ribes, M. Bach-Cuadra, and G. Krüger, “On the convergence of EM-like
algorithms for image segmentation using Markov random ﬁelds,” Medical Image Analysis,
vol. 15, no. 6, pp. 830–9, 2011.
[40] F. Wilcoxon, “Individual Comparisons by Ranking Methods,” Biometrics Bulletin, vol. 1,
no. 6, pp. 80–83, 1945.
[41] P. M. Robson, A. K. Grant, A. J. Madhuranthakam, R. Lattanzi, D. K. Sodickson, and
C. a. McKenzie, “Comprehensive quantiﬁcation of signal-to-noise ratio and g-factor for
image-based and k-space-based parallel imaging reconstructions,” Magnetic resonance
in medicine : ofﬁcial journal of the Society of Magnetic Resonance in Medicine / Society of
Magnetic Resonance in Medicine, vol. 60, pp. 895–907, oct 2008.
[42] C. N. Wiens, S. J. Kisch, J. D. Willig-Onwuachi, and C. A. McKenzie, “Computationally
rapid method of estimating signal-to-noise ratio for phased array image reconstructions,”
Magnetic Resonance in Medicine, vol. 66, pp. 1192–1197, oct 2011.
[43] G. C. Wiggins, C. Triantafyllou, A. Potthast, A. Reykowski, M. Nittka, and L. L. Wald, “32-
Channel 3 tesla receive-only phased-array head coil with soccer-ball element geometry,”
Magnetic Resonance in Medicine, vol. 56, no. 1, pp. 216–223, 2006.
[44] D. Bates, M. Mächler, B. Bolker, and S. Walker, “Fitting Linear Mixed-Effects Models Using
{lme4},” Journal of Statistical Software, vol. 67, no. 1, pp. 1–48, 2015.
[45] J. L. Bernal-Rusiel, D. N. Greve, M. Reuter, B. Fischl, and M. R. Sabuncu, “Statistical
analysis of longitudinal neuroimage data with Linear Mixed Effects models,” NeuroImage,
vol. 66, pp. 249–260, 2013.
[46] A. Kuznetsova, P. B. Brockhoff, and R. H. B. Christensen, “lmerTest: Tests for random and
ﬁxed effects for linear mixed effect models (lmer objects of lme4 package),” R package
version, vol. 2, no. 6, 2013.
[47] O. J. Dunn, “Multiple Comparisons Among Means,” Journal of the American Statistical
Association, vol. 56, no. 293, pp. 52– 64, 1961.
[48] K. P. Cosgrove, C. M. Mazure, and J. K. Staley, “Evolving Knowledge of Sex Differences in
Brain Structure, Function, and Chemistry,” Biological Psychiatry, vol. 62, pp. 847–855, jul
2007.
[49] R. C. Gur, B. I. Turetsky, M. Matsui, M. Yan, W. Bilker, P. Hughett, and R. E. Gur, “Sex
Differences in Brain Gray and White Matter in Healthy Young Adults: Correlations with
Cognitive Performance,” The Journal of Neuroscience, vol. 19, no. 10, pp. 4065–4072, 1999.
[50] P. Falkovskiy, D. Brenner, T. Feiweier, S. Kannengiesser, B. Maréchal, T. Kober, A. Roche,
K. Thostenson, R. Meuli, D. Reyes, T. Stoecker, M. A. Bernstein, J.-P. Thiran, and G. Krueger,
“Comparison of accelerated T1-weightedwhole-brain structural-imaging protocols,” Neu-
roImage, vol. 124, Part, pp. 157–167, 2016.
99
Bibliography
[51] M. Blaimer, F. A. Breuer, M. Mueller, N. Seiberlich, D. Ebel, R. M. Heidemann, M. A.
Griswold, and P. M. Jakob, “2D-GRAPPA-operator for faster 3D parallel MRI,” Magnetic
resonance in medicine : ofﬁcial journal of the Society of Magnetic Resonance in Medicine /
Society of Magnetic Resonance in Medicine, vol. 56, pp. 1359–64, dec 2006.
[52] D. Brenner, R. Stirnberg, E. D. Pracht, and T. Stöcker, “Two-dimensional accelerated
MP-RAGE imaging with ﬂexible linear reordering,” Magma (New York, N.Y.), vol. 27,
pp. 455–62, oct 2014.
[53] F. A. Breuer, M. Blaimer, M. F. Mueller, N. Seiberlich, R. M. Heidemann, M. A. Griswold,
and P. M. Jakob, “Controlled aliasing in volumetric parallel imaging (2D CAIPIRINHA),”
Magnetic resonance in medicine : ofﬁcial journal of the Society of Magnetic Resonance in
Medicine / Society of Magnetic Resonance in Medicine, vol. 55, pp. 549–56, mar 2006.
[54] P. Falkovskiy, T. Kober, D. Reyes, K. Steinert, M. Seeger, M. Bernstein, and G. Krueger,
“SegmentedMulti-EchoMPRAGEAcquisition for Accelerated T1-weightedBrain Imaging,”
in ISMRM, vol. 27, 2013.
[55] C. R. Jack, “Alliance for aging research AD biomarkers work group: structural MRI,”
Neurobiology of aging, vol. 32 Suppl 1, pp. S48–57, dec 2011.
[56] M. I. Miller, C. E. Priebe, A. Qiu, B. Fischl, A. Kolasny, T. Brown, Y. Park, J. T. Ratnanather,
E. Busa, J. Jovicich, P. Yu, B. C. Dickerson, and R. L. Buckner, “Collaborative computational
anatomy: an MRI morphometry study of the human brain via diffeomorphic metric
mapping,” Human brain mapping, vol. 30, pp. 2132–41, jul 2009.
[57] K. L. Mills and C. K. Tamnes, “Methods and considerations for longitudinal structural
brain imaging analysis across development,” Developmental cognitive neuroscience,
vol. 9C, pp. 172–190, jul 2014.
[58] M. Bernstein, “Effect of windowing and zero-ﬁlled reconstruction of MRI data on spatial
resolution and acquisition strategy,” Journal of Magnetic . . . , vol. 280, pp. 270–280, 2001.
[59] P. Shrout and J. Fleiss, “Intraclass correlations: Uses in assessing rater reliability,” Psycho-
logical Bulletin, vol. 86, no. 2, pp. 420–428, 1979.
[60] A. Roche, G. Malandain, and N. Ayache, “Unifying maximum likelihood approaches in
medical image registration,” International Journal of Imaging Systems and Technology,
vol. 11, no. 1, pp. 71—-80, 2000.
[61] R. F. Busse, A. C. S. Brau, A. Vu, C. R. Michelich, E. Bayram, R. Kijowski, S. B. Reeder, and
H. A. Rowley, “Effects of refocusing ﬂip angle modulation and view ordering in 3D fast
spin echo,” Magnetic resonance in medicine : ofﬁcial journal of the Society of Magnetic
Resonance in Medicine / Society of Magnetic Resonance in Medicine, vol. 60, pp. 640–9, sep
2008.
100
Bibliography
[62] A. M. Dale, B. Fischl, and M. I. Sereno, “Cortical Surface-Based Analysis: I. Segmentation
and Surface Reconstruction,” NeuroImage, vol. 9, no. 2, pp. 179–194, 1999.
[63] B. Fischl, M. I. Sereno, and A. M. Dale, “Cortical Surface-Based Analysis: II: Inﬂation,
Flattening, and a Surface-Based Coordinate System,” NeuroImage, vol. 9, no. 2, pp. 195–
207, 1999.
[64] A. J. W. van der Kouwe, T. Benner, D. H. Salat, and B. Fischl, “Brain morphometry with
multiecho MPRAGE,” NeuroImage, vol. 40, pp. 559–69, apr 2008.
[65] A. Macovski, “Noise in MRI,” Magnetic Resonance in Medicine, vol. 36, no. 3, pp. 494–497,
1996.
[66] J. P. Fortin, E. M. Sweeney, J. Muschelli, C. M. Crainiceanu, and R. T. Shinohara, “Removing
inter-subject technical variability in magnetic resonance imaging studies,” NeuroImage,
vol. 132, pp. 198–212, 2016.
[67] R. T. Shinohara, E. M. Sweeney, J. Goldsmith, N. Shiee, F. J. Mateen, P. A. Calabresi, S. Jarso,
D. L. Pham, D. S. Reich, and C. M. Crainiceanu, “Statistical normalization techniques for
magnetic resonance imaging,” NeuroImage: Clinical, vol. 6, pp. 9–19, 2014.
[68] A. Keshavan, F. Paul, M. K. Beyer, A. H. Zhu, N. Papinutto, R. T. Shinohara, W. Stern,
M. Amann, R. Bakshi, A. Bischof, A. Carriero, M. Comabella, J. C. Crane, S. D’Alfonso,
P. Demaerel, B. Dubois, M. Filippi, V. Fleischer, B. Fontaine, L. Gaetano, A. Goris, C. Graetz,
A. Gröger, S. Groppa, D. A. Haﬂer, H. F. Harbo, B. Hemmer, K. Jordan, L. Kappos, G. Kirkish,
S. Llufriu, S. Magon, F. Martinelli-Boneschi, J. McCauley, X. Montalban, M. Muhlau,
D. Pelletier, P. M. Pattany, M. Pericak-Vance, I. Rebeix, M. Rocca, A. Rovira, R. Schlaeger,
A. Saiz, T. Sprenger, A. Stecco, B. M. J. Uitdehaag, P. Villoslada, M. P. Wattjes, H. Weiner,
J. Wuerfel, C. Zimmer, F. Zipp, International Multiple Sclerosis Genetics Consortium.
Electronic address: AIVINSON@PARTNERS.ORG, S. Hauser, J. R. Oksenberg, and R. G.
Henry, “Power estimation for non-standardized multisite studies.,” NeuroImage, vol. 134,
pp. 281–294, 2016.
[69] D. H. Salat, S. Y. Lee, A. J. van der Kouwe, D. N. Greve, B. Fischl, and H. D. Rosas, “Age-
associated alterations in cortical gray and white matter signal intensity and gray to white
matter contrast,” NeuroImage, vol. 48, no. 1, pp. 21–28, 2009.
[70] B. Mortamet, M. a. Bernstein, C. R. Jack, J. L. Gunter, C. Ward, P. J. Britson, R. Meuli,
J.-P. Thiran, and G. Krueger, “Automatic quality assessment in structural brain magnetic
resonance imaging.,” Magnetic resonance in medicine : ofﬁcial journal of the Society of
Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine, vol. 62,
pp. 365–72, aug 2009.
101

Pavel Falkovskiy 
pfalkovskiy@gmail.com 
Ave. Louis-Ruchonnet 35, 1003, Lausanne, Switzerland 
+41-78-915-78-91 
+1-403-288-2076 
 
 
SUMMARY OF QUALIFICATIONS 
? Very strong background in physics and numerical methods 
? Strong knowledge of C\C++, CUDA\OpenCL, Python, Matlab, R 
? Experienced in MR image acquisition\reconstruction 
? Languages: English, Russian, French 
 
EDUCATION 
Candidate for Ph.D. in Electrical Engineering 
École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, 2012-present 
Thesis: Assessment of Image Quality Requirements in Magnetic Resonance Imaging for Quantitative Brain 
    Morphometry 
 
Master of Science in Physics and Applications (Complex Systems) 
Université Pierre-et-Marie-Curie, Paris, France, 2011-2012 
 
Honours Bachelor of Science 
Honours Physics, Biophysics specialization 
University of Waterloo, Waterloo, Ontario, Canada, 2004-2009 
 
WORK EXPERIENCE 
 
2012-present Research Assistant 
Siemens Healthcare, Renens, Switzerland 
? Designed and implemented pulse sequences for accelerated magnetic resonance brain imaging(MRI) 
? Designed and implemented a navigator for motion correction framework 
? Developed automated image quality assessment routines 
 
2011 Research Assistant 
General Electric Healthcare, Buc, France 
? Developed CT image reconstruction algorithm for a GPU using C++\CUDA 
? Ported image preprocessing routines to a GPU 
? Ported legacy linear algebra library to a GPU 
 
2009-2010 Computer Programmer in Research and Development Department 
Athias Geophysical, Calgary, Alberta, Canada 
? Developed applications in C++ for seismic data processing and image reconstruction 
 
2007-2008 Research Assistant 
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 
 
2006 Computer Programmer in Research and Development Department 
Sensors & Software Inc., Mississauga, Ontario, Canada 
 
103

Publications
Journals
P. Falkovskiy, D. Brenner, T. Feiweier, S. Kannengiesser, B. Maréchal, T. Kober, A. Roche, K.
Thostenson, R. Meuli, D. Reyes, T. Stoecker, M. A. Bernstein, J.-P. Thiran, and G. Krueger, “Com-
parison of accelerated T1-weighted whole-brain structural-imaging protocols,” Neuroimage,
vol. 124, pp. 157–167, 2016.
M. Waszak*, P. Falkovskiy*, T. Kober, B. Marechal, R. Mueli, R. Gruetter, and G. Krueger,
"Prospective Head Motion Correction with FID-Triggered Image Navigators," Magnetic reso-
nance in medicine, 2016.
S. Haller*, P. Falkovskiy*, R. Meuli, J.-P. Thiran, G. Krueger, K.-O. Lovblad, T. Kober, A. Roche,
and B. Marechal, “Basic MR sequence parameters systematically bias automated brain volume
estimation,” Neuroradiology, 2016.
Conferences
P. Falkovskiy, T. Kober, D. Reyes, K. Steinert, M. Seeger, M. Bernstein, and G. Krueger, “Seg-
mented Multi-Echo MPRAGE Acquisition for Accelerated T1-weighted Brain Imaging,” in Proc.
Intl. Soc. Mag. Reson. Med. 21, 2013.
P. Falkovskiy, D. Brenner, T. Feiweier, S. Kannengiesser, B. Maréchal, T. Kober, A. Roche, K.
Thostenson, M. Seeger, T. Stoecker, M. Bernstein, and G. Krueger, “Comparison of accelerated
T1-weighted whole-brain structural imaging protocols,” in Proc. Intl. Soc. Mag. Reson. Med.
22, 2014.
M. Babayeva, A. Loktyushin, P. Falkovskiy, T. Kober, R. Mueli, R. Gruetter, and G. Krueger,
“FID navigator triggered acquisition of imaging navigators for retrospective head motion
correction,” in ISMRM workshop on motion correction, in Tromso, Norway, 2014.
T. Hilbert, T. Kober, T. J. Sumpf, Z. Tan, J. Frahm, P. Falkovskiy, H. Meyer, R. Bendl, J. Thiran, R.
Meuli, and G. Krueger, “MARTINI and GRAPPA - When Speed is Taste,” in Proc. Intl. Soc. Mag.
Reson. Med. 22, 2014.
105
Appendix A. Publications
M. Babayeva, P. Falkovskiy, T. Hilbert, G. Bonnier, B. Maréchal, R. Meuli, J. Thiran, R. Gruetter,
G. Krueger, and T. Kober, “Prospective motion correction with FID-triggered image navigators,”
in Proc. Intl. Soc. Mag. Reson. Med. 23, 2015, vol. 66, no. 1
B. Maréchal, S. Kannengiesser, K. Thostenson, P. Kollasch, P. Falkovskiy, J. Thiran, R. Meuli,
and M. A. Bernstein, “A generalized method for automated quality assessment in brain MRI
Introduction:,” in Proc. Intl. Soc. Mag. Reson. Med. 23, 2015.
P. Falkovskiy, B. Maréchal, S. Yan , Z. Jin , T. Qian , K. O’Brien , R. Meuli, J. Thiran , G. Krueger ,
T. Kober , and A. Roche , “Quantitative comparison of MP2RAGE skull-stripping strategies,” in
Proc. Intl. Soc. Mag. Reson. Med. 24, 2016.
P. Falkovskiy, B. Maréchal, T. Kober, P. Maeder, R. Meuli, J. Thiran , and A. Roche , “Impact of
image acquisition systems on Alzheimer’s disease-related atrophy detection,” in Proc. Intl.
Soc. Mag. Reson. Med. 24, 2016.
M. Amann, P. Falkovskiy, A. Thoeni, T. Kober, A. Roche, B. Maréchal, P. Cattin, T. Heye, O. Bieri,
T. Sprenger, C. Stippich, G. Krueger, E. Radue, and J. Wuerfel, “Impact of image acquisition
systems on Alzheimer’s disease-related atrophy detection,” in Proc. Intl. Soc. Mag. Reson.
Med. 24, 2016.
S. Haller, P. Falkovskiy, R. Meuli, J. Thiran, G. Krueger, K. Lovblad, A. Roche, T. Kober, and
B. Maréchal, “Basic MR sequence parameters systematically bias automated brain volume
estimation,” in Proc. Intl. Soc. Mag. Reson. Med. 24, 2016.
106

